Archive

Category Archives for "News"

Sichenzia Ross Ference Carmel LLP represents BriaCell Therapeutics in $8.5 Million Offering

briacell therapeutics

Press Release – New York, NY – September 12, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX: BCT) , a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, in its registered offering of 12,325,000 common shares. Each common share was sold at an offering price of $0.69 per share for gross proceeds of approximately $8.5 million.  

The SRFC team was led by partners Gregory Sichenzia and Avital Perlman, and associates Christian Lichtenberger and Benasz Hansotia.

Sichenzia Ross Ference Carmel LLP Represents NuZee, Inc. in Two PIPE Transactions Totaling $4.3 Million

Press Release – New York, NY – September 11, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented NuZee, Inc. in two recent PIPE transactions, resulting in gross proceeds of approximately $4.3 million. In the first PIPE transaction, the Company sold approximately $3 million of its common stock, which closed on July 18, 2024. In the second PIPE transaction, the Company sold $1.3 million of convertible notes, which closed on September 10, 2024.  

The SRFC team was led by partner Huan Lou and associates Martryn Mak and Bonnie Bai.

Sichenzia Ross Ference Carmel LLP Represents WallachBeth Capital LLC and Revere Securities LLC in the $9 Million Initial Public Offering of Trident Digital Tech Holdings Ltd.

New York, NY – September 12, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented WallachBeth Capital LLC and Revere Securities LLC in an initial public offering of Trident Digital Tech Holdings Ltd., comprised of 1,800,000 American Depositary Shares (“ADSs”).The ADSs are expected to begin trading on the Nasdaq Capital Market on September 10,2024, under the symbol “TDTH.” The closing of the Offering is expected to occur on September 11,2024, subject to the satisfaction of customary closing conditions.

WallachBeth Capital LLC acted as the Lead Underwriter for the Offering and Revere Securities LLC acted as the Co-Manager for the Offering. The WallachBeth team was led by Doug Bantum, Gene McNeill and Ken Bantum. The Revere team was led by Adam Cavise and Jack Chen.

The SRFC team was led by partners Ross Carmel, Barry Biggar and associate Bonnie Bai.

Sichenzia Ross Ference Carmel LLP Represents EF Hutton in the $4 Million Private Placement of Solidion Technology, Inc.

Solidion logo

New York, NY – September 11, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented EF Hutton as exclusive placement agent for the $4 million private placement from Solidion Technology, Inc.

The EF Hutton team was led by David Boral, Gaurav Verma and Mark Iorio.

The SRFC team was led by partner Ross Carmel.

Sichenzia Ross Ference Carmel LLP Represents Joseph Gunnar & Co., LLC in $0.4 Million Registered Direct Offering of Eastside Distilling

Eastside distilling

Press Release – New York, NY – September 6, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Joseph Gunnar & Co.as exclusive placement agent for the $0.4 million registered direct offering from Eastside Distilling.

The Joseph Gunnar & Co. team was led by Chairman & Chief Executive Officer Joseph Alagna, Managing Director Peter Serra and Vice President Vincent Miscioscia.

The SRFC team was led by partners Ross Carmel and Matt Siracusa and associate Christian Lichtenberger.

Sichenzia Ross Ference Carmel LLP Represents Qualigen Therapeutics, Inc. in $3.47 Million Public Offering

qualigen logo

Press Release – New York, NY – September 6, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Qualigen Therapeutics, Inc. in the pricing of its $3.47 million public offering.

Univest Securities, LLC acted as the exclusive placement agent for the offering, led by Bradley Richmond.

The SRFC team was led by partner Ross Carmel and associates Bonnie Bai and Jesse Blue.

Sichenzia Ross Ference Carmel LLP Represents 60 Degrees Pharmaceuticals, Inc. in $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Press Release – New York, NY – September 4, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented 60 Degrees Pharmaceuticals, Inc. (“60P”) in its $4 million private placement priced at-the-market (ATM) under Nasdaq rules.

H.C. Wainwright acted as the exclusive placement agent for the private placement.

The SRFC team was led by partners Ross Carmel, counsel Jeff Hua and associate Tong Wu.

Sichenzia Ross Ference Carmel LLP represents Virax Biolabs Group Limited in a $5 Million Registered Direct Offering

virax biolabs logo

Press Release – New York, NY – August 23, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Virax Biolabs Group Limited (NASDAQ: VRAX) (“Virax”), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, in a $5 million registered direct offering to certain institutional investors.

Virax issued an aggregate of 1,108,892 of its ordinary shares at a purchase price of $4.50 per share.

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.

The SRFC team was led by partners Greg Sichenzia, Barrett DiPaolo and Matt Siracusa and associate Benasz Hansotia

Sichenzia Ross Ference Carmel LLP Represents Wilson-Davis & Co., Inc. in $11.25 Million Initial Public Offering of Ordinary Shares of JBDI Holdings Limited

JBDI Holdings logo

Press Release – New York, NY – August 29, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Wilson-Davis & Co., Inc. in a $11.25 million initial public offering of ordinary shares of JBDI Holdings Limited (NASDAQ: JBDI), a leading provider of environmentally friendly and efficient reconditioning and recycling services for drums and containers in Singapore and Southeast Asia. The initial public offering consisted of 1,750,000 ordinary shares issued and sold by JBDI Holdings Limited and 500,000 ordinary shares by certain selling shareholders at the public
offering price of $5.00 per share.

Wilson-Davis & Co., Inc. acted as lead underwriter and representative for the offering.

The Sichenzia Ross Ference Carmel LLP team was led by partners Benjamin Tan and Matthew Siracusa.

Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in $20 Million PIPE and Warrant Exercise of Uber and NVIDIA-backed Serve Robotics Inc.

serve robotics logo

New York, NY – August 28, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Aegis Capital Corp. as exclusive placement agent in connection with a securities purchase agreement resulting in gross proceeds of $20 million to Serve Robotics Inc. (Nasdaq: SERV).  Backed by Uber and NVIDIA, Serve Robotics develops advanced, AI-powered, low-emissions sidewalk delivery robots that endeavor to make delivery sustainable and economical.  Serve Robotics was spun off from Uber in 2021.  The transaction closed on August 28, 2024.

Serve Robotics completed a private placement to a single institutional investor of pre-funded warrants to purchase up to 555,555 shares of the company’s common stock, together with a warrant to purchase up to 555,555 shares of common stock at an exercise price of $10.00 per share. Each unit of pre-funded warrant and common warrant was sold at a purchase price of $9.00. The common warrants are exercisable upon issuance and will expire five and a half years from the date of issuance.

In addition, Serve Robotics agreed with a single institutional investor to exercise for cash certain outstanding warrants to purchase an aggregate of 2,500,000 shares of Common Stock at their original exercise price of $6.00 per share, for gross proceeds of $15 million. In consideration for such exercise, the investor received, in a private placement, new warrants to purchase up to 2,200,000 shares of common stock with an exercise price of $10.00 per share. These new warrants are exercisable upon issuance and will expire five and a half years from the date of issuance.

Aegis Capital Corp. acted as the exclusive placement agent for the transaction.

The Firm previously represented Aegis Capital as exclusive placement agent in a $15 million private placement offering by Serve Robotics of common stock warrants and pre-funded common stock warrants in July 2024; as the sole book-running manager in Serve Robotics’ $40 million underwritten public offering of common stock and uplisting to Nasdaq in April 2024; and as co-placement agent in Serve Robotics’ $15.7 million “APO” reverse merger and private placement in July – October 2023.  The Firm also represented Laidlaw & Company (UK) Ltd. as co-placement agent in a $3 million convertible note bridge financing for Serve Robotics in April 2023.

The SRFC team was led by partners Gregory Sichenzia, Barrett DiPaolo and Matthew Siracusa and associate Benjamin Sklar.

Sichenzia Ross Ference Carmel LLP Represents Cathay Securities, Inc. in the $8.5 million IPO of Reitar Logtech Holdings Limited

reitar logo

New York, NY – August 27, 2024 – Sichenzia Ross Ference Carmel LLP today announced that it represented Cathay Securities, Inc. in the $8.5 million IPO of Reitar Logtech Holdings Limited (Nasdaq: RITR) (the “Company”), a comprehensive logistics solutions provider in Hong Kong.

Cathay Securities, Inc. is acting as sole book runner and lead underwriter for the Offering. The Cathay Securities team was led by Shell Li.

The SRFC team was led by partners Ross Carmel, Barry Biggar and associate Bonnie Bai.

Sichenzia Ross Ference Carmel LLP Represents Dominari Securities in a $4.4 Million Private Placement of Jones Soda Co.

Jones soda Co. logo

New York, NY – August 23, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Dominari Securities LLC (“Dominari”), in a $4.4 million private placement of Jones Soda Co, a leading developer of sodas and cannabis-infused beverages.

The Dominiari Securities LLC team was led by Kyle Wool and Dr. Cosme Ordonez.

The SRFC team was led by partner Ross Carmel and associate Mohit Agrawal.

Sichenzia Ross Ference Carmel LLP represents EF Hutton LLC in a $2.9 Million Public Offering of New Horizon Aircraft

New Horizon Aircraft Ltd.

Press Release – New York, NY – August 21, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented EF Hutton LLC in a $2.9 million public offering of New Horizon Aircraft Ltd. (NASDAQ: HOVR), an advanced aerospace engineering company that is developing one of the world’s first hybrid eVTOL.

The SRFC team was led by partners Darrin Ocasio, Avital Perlman, Matthew Siracusa, and associate Jesse Blue.

Sichenzia Ross Ference Carmel LLP Represents EF Hutton LLC in a $16 Million Debt Financing Transaction

NRX pharmaceuticals logo

New York, NY – August 19, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented EF Hutton LLC in a $16 million debt financing transaction between NRx Pharmaceuticals, Inc. (“NRx Pharmaceuticals” or the “Company”), a clinical-stage biopharmaceutical company and Anson Funds.

EF Hutton LLC acted as the exclusive placement agent for the Financing.

The SRFC team was led by partner Ross Carmel.

Sichenzia Ross Ference Carmel LLP Represents Siyata Mobile Inc. in a $4 Million Public Offering

siyata mobile logo

New York, NY – August 19, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Siyata Mobile Inc. (“Siyata” or the “Company”), a global developer and vendor of Push-to-Talk over Cellular (PoC) handsets and accessories, in a $4 million public offering.

Spartan Capital Securities, LLC acted as the sole placement agent in connection with the offering.

The SRFC team was led by partners Ross Carmel, Thiago Spercel, and associate Mohit Agrawal.

Sichenzia Ross Ference Carmel LLP represents Greenlane Holdings, Inc. in a $6.5 Million Private Placement

Greenlane logo

Press Release – New York, NY – August 14, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Greenlane Holdings, Inc. (NASDAQ:GNLN) (“Greenlane” or the “Company”), a premier global platform for the development and distribution of premium cannabis accessories, packaging, vape solutions, and lifestyle products, in the closing of a $6.5 million private placement before deducting fees to the placement agent and other offering expenses payable by the company. 

The Company issued an aggregate of 2,363,637 units and pre-funded units. The pre-funded units will be sold at the same purchase price as the units, less the pre-funded warrant exercise price of $0.001. Each unit and pre-funded unit consisted of one share of common stock (or one pre-funded warrant) and two common warrants, each exercisable for one share of common stock at an exercise price of $2.50 per share. The common warrant will be exercisable on the initial exercise date described in the common warrant and will expire 5 years from such date.

Aegis Capital Corp. acted as the Exclusive Placement Agent for the private placement.

The SRFC team was led by partner Arthur Marcus, associate Jesse Blue, and Paralegal Kennedy McCann

Sichenzia Ross Ference Carmel LLP Represents WallachBeth Capital, LLC in $8.6 Million Initial Public Offering of QMMM Holdings Limited

QMMM Holdings logo

New York, NY – August 12, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented WallachBeth Capital LLC (the “Underwriter”) in the initial public offering and partial exercise of the Underwriters’ over-allotment option of the ordinary shares of QMMM Holdings Limited (“QMMM”). The ordinary shares commenced trading on The Nasdaq Capital Market on July 19, 2024. The initial public offering consisted of 2,150,000 ordinary shares of QMMM at a price of $4.00 per share and closed on July 22, 2024. The partial exercise of the Underwriters’ over-allotment option closed on August 8, 2024. 

QMMM is a digital media advertising, virtual avatar & virtual apparel technology service provider in Hong Kong. 

The SRFC team was led by partners Huan Lou, David Manno and associate Christian Lichtenberger.  

Sichenzia Ross Ference Carmel LLP Ranks Third Among Securities Law Firms in PlacementTracker’s PIPE and Private Placement Markets League Tables for Q2 2024

Sichenzia Ross Ference Carmel LLP Ranks Third Among Securities Law Firms in PlacementTracker’s PIPE and Private Placement Markets League Tables for Q2 2024

Press Release – New York, NY – August 7, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it was ranked third nationally among securities law firms in the Issuer Counsel category for PIPE and private placement markets in Q2 2024. SRFC was also included among the top ten for the category of Placement Agent Counsel League Table by number of transactions. The report can be found here.

During the quarter, SRFC provided counsel for 18 transactions on behalf of issuers and investment banks, right behind Goodwin Proctor LLP (22) and Cooley LLP (21). A total of $32.8 billion was raised in 699 transactions throughout Q2 2024. Deal volume decreased 1% (707 deals in Q2 2023) and dollar volume increased 33% ($24.6 billion in Q2 2023).

“Sichenzia Ross Ference Carmel succeeds on behalf of its clients because of our deep experience coupled with speed and flexibility, all traits required for issuers and banks to thrive in today’s market,” said Ross Carmel, name partner at Sichenzia Ross Ference Carmel LLP.

PlacementTracker is the leading source for data and analysis to institutions in the PIPE and Private Placement markets. Legal counsel rankings exclude all 144-A Offerings, Equity Lines of Credit, At the Market Transactions, Rights Offerings, Bought Deals, and all PIPE transactions conducted by foreign issuers that trade in the U.S. on the OTC.

“In the early 2000s our firm was among the first to represent mid and small cap issuers in a new financing strategy called PIPES and Private Placements,” said Gregory Sichenzia, founding partner at Sichenzia Ross Ference Carmel LLP. “We were recognized as an industry leader in this space then and continue to be nearly a quarter century later. It’s a great testament to our ingenuity and our consistent quality of counsel. Many have come after us, but there is only one original.”

About Sichenzia Ross Ference Carmel LLP
SRFC is a full-service law firm with a nationally recognized corporate, securities, and litigation practice that provides experienced representation in all matters involving the securities industry. In addition to handling routine to complex commercial matters, SRFC’s renowned litigation and regulatory department specializes in defending broker-dealers, registered persons, public and private corporations, and individuals in investigations and enforcement proceedings before the SEC, FINRA, and other regulatory bodies, as well as litigations and arbitrations across all forums in the securities industry, including class action lawsuits, shareholder derivative actions, and matters involving allegations of fraud, misrepresentation or other securities violations.

Sichenzia Ross Ference Carmel LLP Represents MKDWELL Tech Inc. in Business Combination with Cetus Capital Acquisition Corp.

MKDW logo

Press Release New York, NY August 6, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented MKDWELL Tech Inc. (NASDAQ: MKDW) (“MKD” or the “Company”) as U.S. counsel in the successful completion of its previously announced business combination with Cetus Capital Acquisition Corp.

The ordinary shares of the Company began trading on the Nasdaq Global Market on August 1, 2024, under the ticker symbol “MKDW” and the Company’s warrants began trading on the Nasdaq Capital Market on the same date under the ticker symbol “MKDWW”. MKD is an automotive electronics manufacturer and operates primarily through its key subsidiaries: MKD Jiaxing and MKD Shanghai in Mainland China, and MKD Taiwan in Hsinchu, Taiwan. 

Partner David Manno commented, “We congratulate MKD on the completion of their business combination and Nasdaq listing.” 

The Sichenzia Ross Ference Carmel LLP team was led by partners Huan Lou and David Manno and associates Martryn Mak and Ronghong Dai.

Sichenzia Ross Ference Carmel LLP Represents WallachBeth Capital in a $1.75 Million Registered Direct, Concurrent Private Placement and Warrant Inducement of bioAffinity Technologies, Inc. 

bio affinity

New York, NY – August 6, 2024 – Sichenzia Ross Ference Carmel LLP announced it has represented WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, in a registered direct, concurrent private placement and warrant inducement of bioAffinity Technologies, Inc. priced at $1.75 million.

The SRFC team was led by partners Ross Carmel, Jeff Wofford and associate Soumya Cheedi.

Sichenzia Ross Ference Carmel LLP Represents Brookline Capital Markets in the $6.4 Million Initial Public Offering of OS Therapies Incorporated

os therapies

New York, NY – August 2, 2024 – Sichenzia Ross Ference Carmel LLP (SRFC) represented Brookline Capital Markets, a division of Arcadia Securities LLC, in the $6.4 million initial public offering of OS Therapies Incorporated (NYSE: OSTX), a clinical stage oncology company focused on the treatment of osteosarcoma and other solid tumors in children and young adults.

Brookline Capital Markets acted as the sole book-running manager for the offering.

The SRFC team was led by partners Marc Ross and Tom Rose, and associate Benjamin Sklar.

Sichenzia Ross Ference Carmel LLP Represents Nature’s Miracle Holding Inc. in $1.2 Million Public Offering

natures miracle

Press ReleaseNew York, NYAugust 2, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Nature’s Miracle Holding Inc. (NASDAQ: NMHI; NMHIW), a growing agriculture technology company providing equipment and services to growers in the Controlled Environment Agriculture industry, in approximately $1.2 million public offering of 5,000,000 units at a public offering price of $0.24 per unit, with each unit consisting of one share of common stock and one Series A warrant to purchase one share of common stock.  EF Hutton LLC acted as the sole book running manager for the offering.

The Sichenzia Ross Ference Carmel LLP team was led by partners Huan Lou and David Manno, counsel Jeffrey Hua and associate Ronghong Dai.

Sichenzia Ross Ference Carmel LLP Represents A.G.P./Alliance Global Partners  in the $69 Million Initial Public Offering of DT Cloud Star Acquisition Corporation  

DT Cloud Star Acquisition Logo

Press Release – New York, NY – August 2, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented A.G.P. / Alliance Global Partners in the $69 million initial public offering, including full exercise of Underwriter’s Over-Allotment Option, of DT Cloud Star Acquisition Corporation, a blank check company. The offering consisted of 6,900,000 units at a price of $10.00 per unit.  This includes the exercise in full by the underwriters’ over-allotment option to purchase up to an additional 900,000 units. Each unit consists of one ordinary share and one right to receive one-ninth (1/9) of one ordinary share upon the consummation of an initial business combination. The IPO closed on July 26, 2024.  The units are listed on The Nasdaq Global Market (“Nasdaq”) and began trading under the ticker symbol “DTSQU” on July 25, 2024. Once the securities comprising the units begin separate trading, the ordinary shares and the rights are expected to be traded on Nasdaq under the symbols “DTSQ” and “DTSQR,” respectively.  

The Sichenzia Ross Ference Carmel LLP team was led by partners Huan Lou, David Manno, and associates Martryn Mak and Ronghong Dai.

 

Sichenzia Ross Ference Carmel LLP Represents ThinkEquity in a $5 Million Public Offering

better choice company

New York, NY – July 31, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented ThinkEquity in a $5 million public offering of Better Choice Company Inc. (NYSE American: BTTR) (the “Company” or (“Better Choice”), a pet health and wellness company.

ThinkEquity is acting as the sole book-runner for the offering. Its team was led by Joe (Ramnarain) Jaigobond, Eric Lord and Christopher Penny.

The SRFC team was led by partners Ross Carmel, Jay Yamamato, Jeff Cahlon, law clerk Rohini Sud and associate Benasz Hansotia.

Sichenzia Ross Ference Carmel LLP Represents ThinkEquity in a $10.8 Registered Direct Offering

New York, NY – July 30, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented ThinkEquity in a $10.8 registered direct offering of CEL-SCI Corporation (“CEL-SCI” or the “Company”), a cancer immunotherapy company.

ThinkEquity is acting as sole placement agent for the offering. Its team was led by Joe (Ramnarain) Jaigobond, Eric Lord, and Brian Carstens.

The SRFC team was led by partners Ross Carmel, Avital Perlman and associate Soumya Cheedi.

Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in $15 Million PIPE of Uber and NVIDIA-backed Serve Robotics Inc.

serve robotics logo

New York, NY – July 24, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Aegis Capital Corp. as exclusive placement agent in a $15 million private placement offering by Serve Robotics Inc. (Nasdaq: SERV) of common stock warrants and pre-funded common stock warrants. Backed by Uber and NVIDIA, Serve Robotics develops advanced, AI-powered, low-emissions sidewalk delivery robots that endeavor to make delivery sustainable and economical.  Serve Robotics was spun off from Uber in 2021.  The Firm previously represented Aegis Capital as the sole book-running manager in Serve Robotics’ $40 million underwritten public offering of common stock and uplisting to Nasdaq in April 2024, and as co-placement agent in Serve Robotics’ $15.7 million “APO” reverse merger and private placement in July – October 2023.  The Firm also represented Laidlaw & Company (UK) Ltd. as co-placement agent in a $3 million convertible note bridge financing for Serve Robotics in April 2023.

The SRFC team was led by partners Gregory Sichenzia, Barrett DiPaolo and Matthew Siracusa and associate Benjamin Sklar.

The PIPEs Conference (A Dealflow Event): November 13-14, 2024

Sichenzia Ross Ference Carmel LLP partner Ross Carmel will speak at this year’s PIPEs Conference, a DealFlow Event, at the Hard Rock Hotel & Casino in Hollywood, Florida. Join Ross to explore the evolution of the PIPE market, regulatory updates, and market trends.

For 20 years, the DealFlow team has been at the forefront of private investments in public equity, starting with The PIPEs Report and PrivateRaise. We’ve hosted The PIPEs Conference in cities around the world. Our next stop? Hollywood, Florida.

This year’s conference at The Hard Rock Hotel & Casino will again be a hub for professional networking and deal-making. We’ll be exploring the PIPE market’s evolution and delve into the latest regulatory updates, market trends, notable transaction structures, and more.

Please click this link to register or learn more.

Sichenzia Ross Ference Carmel LLP Represents EF Hutton LLC in a $2 Million Underwritten Public Offering 

shineco logo

New York, NY – July 12, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented EF Hutton LLC in a $2 Million Underwritten Public Offering of Shineco, Inc., a provider of innovative diagnostic medical products and related medical devices. 

EF Hutton LLC is acting as the sole book-running manager for the offering. Its team was led by David Boral, Stephanie Hu, Ryan Zhang and Mark Iorio.

The SRFC team was led by partners Ross Carmel, Matt Siracusa and Rohini Sud. 

Sichenzia Ross Ference Carmel LLP Represents Vyome Therapeutics in a Merger Agreement with ReShape Lifesciences

New York, NY – July 11, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Vyome Therapeutics, Inc., a private clinical-stage healthcare company targeting immuno-inflammatory and rare diseases, in connection with the execution of a definitive merger agreement with ReShape Lifesciences Inc, the premier physician-led weight loss and metabolic health-solutions company.  Vyome and ReShape will combine in an all-stock transaction, and be listed on Nasdaq under the new ticker symbol “HIND.”

The SRFC team was led by partners Gregory Sichenzia, Marcelle Balcombe and Glenn Burlingame and associate, Nishkarsh Jakhar.

Sichenzia Ross Ference Carmel LLP Represents Spartan Capital Securities LLC in a $6 Million Public Offering of Inspire Veterinary Partners, Inc.

inspire veterinary partners

New York, NY – July 8, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Spartan Capital Securities LLC in a $6 million public offering of Inspire Veterinary Partners, Inc., an owner and provider of pet health care services throughout the U.S.

Spartan Capital Securities LLC was the sole placement agent in connection with the offering. Its team was led by Joe Giamichael and Harry Warnick.

The SRFC team was led by partners Ross Carmel, Jeff Wofford and associate Soumya Cheedi.

Sichenzia Ross Ference Carmel LLP Represents EF Hutton in a $2.25 Million Registered Direct Offering of Datasea Inc.

datasea inc. logo

Press Release – New York, NY – July 2, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented EF Hutton in a $2.25 million registered direct offering of Datasea Inc., a Nevada corporation engaged in innovative businesses in high-tech intelligent acoustics and 5G-Artificial Intelligence (“AI”) multimodal communication technology in the United States and China.

EF Hutton LLC was the exclusive placement agent for the offering. Its team was led by David Boral, Stephanie Hu, Mark Iorio and Ryan Zhang.

The SRFC team was led by partners Ross Carmel, Avital Perlman and associate Bonnie Bai.

Law360: “Sichenzia Ross Guiding Fuel Cell Co. on $130M SPAC Merger”

Law360, a top trade publication providing news coverage and analysis on legal developments including litigation filings, case settlements, verdicts, regulation, enforcement, legislation, corporate deals and more, recently published an article on Sichenzia Ross Ference Carmel LLP representing Infintium Fuel Cell Systems, Inc. in a business combination with Goldenstone Acquisition Limited. The Law360 article can be found here, and details on the transaction are available at this link.

The SRFC team was led by partners Ross Carmel, Shane Wu, Glen Burlingame, and associate Lony Leung.

Sichenzia Ross Ference Carmel LLP Represents Ayurcann Holdings Corp. in a Business Combination with Arogo Capital Acquisition Corp.

ayurcann logo

New York, NY – June 27, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it has represented Ayurcann Holdings Corp. (“Ayurcann” or the “Company”), an award winning Canadian cannabis extraction company specializing in the processing and manufacturing of pharma grade cannabis and hemp for various derivative cannabis products, in a business combination with Arogo Capital Acquisition Corporation (“Arogo”), a special purpose acquisition company.

The SRFC team was led by partners Ross Carmel, Glenn Burlingame and counsel Sharon Carroll.

Sichenzia Ross Ference Carmel LLP Represents Madison Global Partners, LLC, in a $11 Million Registered Direct Offering of authID, Inc.

Auth ID inc. logo

Press Release – New York, NY – June 27, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Madison Global Partners, LLC, in a registered direct offering of the securities of authID, Inc. (NASDAQ: AUID) (“The Company”), a leading provider of innovative biometric identity verification and authentication solutions. The company sold 1,464,965 million shares of its common stock at a purchase price of $7.50 per share (however, the purchase price for one share if the investor was a director of the Company was $8.16). The aggregate gross proceeds from the Offering were $11,000,000 Million before deducting placement agent fees and other estimated offering expenses.

authID (Nasdaq: AUID) ensures enterprises “Know Who’s Behind the Device™” for every customer or employee login and transaction through its easy-to-integrate, patented, biometric identity platform. authID quickly and accurately verifies a user’s identity and eliminates any assumption of ‘who’ is behind a device to prevent cybercriminals from compromising account openings or taking over accounts. Combining secure digital onboarding, FIDO2 passwordless login, and biometric authentication and account recovery, with a fast, accurate, user-friendly experience, authID delivers biometric identity processing in 700ms. Binding a biometric root of trust for each user to their account, authID stops fraud at onboarding, detects and stops deepfakes, eliminates password risks and costs, and provides the fastest, frictionless, and the most accurate user identity experience demanded by today’s digital ecosystem. Discover more at www.authID.ai.

The Sichenzia Ross Ference Carmel LLP team was led by partners Greg Sichenzia, Darrin Ocasio, and associate Jesse Blue.

Click here to view other recent transactions from the SRFC team.

Sichenzia Ross Ference Carmel LLP Represents Infintium Fuel Cell Systems, Inc. in a Business Combination with Goldenstone Acquisition Limited

Infintium Fuel Cell Systems, Inc.

New York, NY – June 27, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Infintium Fuel Cell Systems, Inc. (“Infintium” or the “Company”), a Greer, South Carolina based hydrogen fuel cell technology provider to some of the world’s largest commercial, industrial and retail companies, in a business combination agreement with Goldenstone Acquisition Limited (“Goldenstone”), (NASDAQ: GDST), a Delaware blank check company.

The SRFC team was led by partners Ross CarmelShane Wu, Glen Burlingame, and associate Lony Leung.

Sichenzia Ross Ference Carmel LLP Represents Kaival Brands in a $6 Million Public Offering 

Kaival brands logo

New York, NY – June 24, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Kaival Brands Innovations Group, Inc., (NASDAQ: KAVL) (“Kaival Brands”, the “Company”), the exclusive U.S. distributor of all products manufactured by Bidi Vapor, LLC (“Bidi Vapor”) in a $6.0 million public offering. The team announced the pricing of a public offering of 3,921,500 units at a public offering price of $1.53 per unit (the “Offering”).

Maxim Group LLC is the placement agent.

The SRFC team was led by partners Ross Carmel, Jeff Wofford and associate Soumya Cheedi.

Sichenzia Ross Ference Carmel LLP represents Presidio Property Trust, Inc. in Pricing of $1.74 Million Public Offering of Series D Preferred Stock

presidio property trusts logo

Press Release – New York, NY – June 21, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Presidio Property Trust, Inc., an internally managed, diversified real estate investment trust, in the pricing of its public offering of 109,054 shares of its 9.375% Series D Cumulative Redeemable Perpetual Preferred Stock par value $0.01 per share (the “Series D Preferred Stock”) at a price to the public of $16.00 per share. 

The SRFC team was led by partners Darrin M. Ocasio and Avital Perlman, associate Rohini Sud, and law clerk Nishkarsh Jakhar.  

Sichenzia Ross Ference Carmel LLP Represents MGO Global in a Business Combination Agreement with Heidmar

New York, NY – June 21, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented MGO Global Inc, a digitally-native, lifestyle brand portfolio company, (“MGO”, “MGO Global”, or the “Company”) in a business combination agreement with Heidmar, Inc., a global leader in the crude oil and refined petroleum product tanker market (“Heidmar”).

The SRFC team was led by partners Ross Carmel, Jeff Wofford, Glenn Burlingame, and associate Anna Chaykina.

Sichenzia Ross Ference Carmel LLP Represents Sharps Technology, Inc. in $3.4 Million Reg A+ Warrant Inducement Offering

Sharps Technology inc.

Press Release – New York, NY – June 17, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Sharps Technology, Inc. (NASDAQ: STSS), an innovative medical device and pharmaceutical company offering patented, best-in-class syringe products, in a $3.39 million Reg A+ warrant inducement offering. The offering combined a Reg A offering on Form 1-A and the exercise of existing warrants. 

The Sichenzia Ross Ference Carmel LLP team was led by partner Arthur Marcus and associate Jesse Blue.

Sichenzia Ross Ference Carmel Represents Joseph Gunnar & Co., LLC in a $3 Million Private Placement for Beeline Financial Holdings Inc.

beeline holdings logo
Press Release – June 5, 2024 – New York, NY – Sichenzia Ross Ference Carmel LLP today announced it represented Joseph Gunnar & Co., LLC in a $3 million private placement for Beeline Financial Holdings Inc., a fintech mortgage lender. The SRFC team was led by partner Ross Carmel, counsel Sharon Carrol, and Associate Christian Lichtenberger.

Sichenzia Ross Ference Carmel LLP Represents BioSig Technologies, Inc. in $3 Million Registered Direct Offering

biosig technologies logo

Press Release – New York, NY – May 30, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented BioSig Technologies, Inc. (NASDAQ: BSGM), a medical technology company committed to delivering unprecedented accuracy and precision to intracardiac signal visualization, in a $3 million registered direct offering. The Company sold an aggregate of 1,507,683 shares of common stock in a registered direct offering at a purchase price of $1.91 per share, along with a concurrent private placement of warrants to purchase 1,570,683 shares of common stock at an exercise price of $1.78 per share. H.C. Wainwright & Co acted as the sole placement agent for the offering.  

The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory SichenziaBarrett S. DiPaolo, and Avital Perlman, and associates Christian Lichtenberger and Mayank Pradhan

Sichenzia Ross Ference Carmel LLP represents Presidio Property Trust, Inc. in Shareholder Activism Matter

Press Release – New York, NY – May 17, 2024 – Sichenzia Ross Ference Carmel LLP served as a legal advisor to Presidio Property Trust, Inc. (“Presidio” or the “Company”), an internally managed, diversified real estate investment trust, in connection with its defense against director nominations from an activist shareholder group. 

The Company entered into a cooperation agreement with the shareholder group and appointed one of the members of the group to its board. The shareholder group agreed to withdraw the five director nominations it had previously submitted to Presidio and to support the Presidio board’s slate of directors at the Company’s 2024 Annual Meeting of Stockholders. The shareholder activist group has also agreed to certain customary standstill provisions and voting commitments.   

The SRFC team was led by partners Darrin M. Ocasio, Avital Perlman, Glenn Burlingame, and associate Lony Leung.

Sichenzia Ross Ference Carmel LLP Represents BriaCell Therapeutics Corp. in $5 Million Registered Direct Offering

briacell therapeutics

Press Release – New York, NY – May 17, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX: BCT), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, in a $5 million registered direct offering.  The Company sold an aggregate of 2,402,935 common shares (or pre-funded warrants in lieu thereof) and warrants to purchase 2,402,935 common shares.  A.G.P./Alliance Global Partners acted as the sole placement agent for the offering.  

The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory Sichenzia, Avital Perlman, Glenn Burlingame, law clerk Soumya Cheedi, and senior paralegal Raquel Vazquez.

CLIENT ALERT: Employer and Employee Update on Nationwide Ban of Non-competes – “Wait and See” or “Roll The Dice”

September 4, 2024 is the day. If the courts do not issue an order prohibiting the enforcement of all or any part of the non-compete rule, it will be the law of the land starting September 4, 2024.

The legal challenges have already been-fast-tracked. We expect a decision on whether the non-compete rule stands or falls, in whole or in part, in July 2024. For employers and employees, in practice that means there is just 4 to 6 weeks of actual lead time before a possible decision and the effective date of September 4, 2024.

If you are deciding whether to change employment, renegotiate the terms of employment or enforce your current employment contract rights, you do not have 120 more days to consider – you have just four to six weeks to explore, perform diligence, decide and act.

Second, without alteration, the non-compete rule applies to all business sectors, most business entity forms, and both publicly-traded and private companies. It is retroactive in reach, and it will touch almost every level of employment except for the very highest level of C-suite executives – potentially applying to even executive officers who sit at the top of their distinct business lines, divisions, groups or departments. Only the top decision-maker(s) will be excluded from the ban.

Employers are reassessing the profiles, functions, needs and compensation of their employees in order to decide how best to protect their interests and align their employees’ interests with their own. Employers that pay highly competitive salaries, commissions, and bonuses and invest in the tools, training, credentialing, and licensing of their employees should re-evaluate the “value of the total employment package” without restraints against competition, including the timing and conditions of those pay packages to retain talent and disincentive employees from “taking the money and running” for the next best offer.

Whether you view this as employers “handcuffing” employees to their business or employers protecting their investments in people and competitive “know-how,” decisions must be made.

This is especially true across service sectors. In the financial services sector, banks, funds, investment advisors and broker-dealers, should re-evaluate how to assert greater ownership and control over investors and account customers who are the underlying assets. Employees should re-evaluate the advantages of the status quo versus greater mobility and better compensation in the future. In technology, advertising and marketing, employers and employees should re-evaluate how a non-compete ban would impact talent, intellectual property and the lucrative client relationships that drive those sector dollars.

Do you sit tight or “roll the dice?” If you have questions, please contact Scott Furst at SRFC at (212) 930-9700 or sfurst@srfc.law

About The Author

daniel scott furst

Scott Furst is a member of Sichenzia Ross Ference Carmel’s Business Litigation & Arbitration, Broker-Dealer Regulation and Compliance Groups. He has extensive civil litigation, regulatory action, investigations and enforcement defense experience with a specialization in securities, business, complex commercial litigation and employment matters involving senior executives, including with regard to contract disputes, investor, shareholder and member disputes, covenants litigation and statutory discrimination claims, in state and federal courts, before the Securities and Exchange Commission, Financial Industry Regulatory Authority, American Arbitration Association, and JAMS. Mr. Furst also routinely advises, negotiates and drafts employment and transactional agreements for senior executives across all business sectors, including officers and investors in the fund structure and formation space for private equity funds, hedge funds, real estate funds and hybrid vehicles for alternative investments.

Sichenzia Ross Ference Carmel LLP Litigation Partners Michael Ference and Scott Furst Resolve SEC Enforcement Action After Securing Broad Dismissal of Securities Law Claims And Handing SEC A Rare Defeat On Section 5 Liability

Press Release – New York, NY – May 13, 2024 – Led by Partner Scott Furst, Sichenzia Ross Ference Carmel LLP (“SRFC”) won successive victories for their client, when, in January 2020, Southern District of New York Senior Judge Loretta Preska dismissed all fraud-based securities and control person liability claims brought by the Securities and Exchange Commission (“SEC”) against their client in S.E.C. v. Magna Equities II, LLC, et al., Case No. 1:19-cv-01459 (LAP).  In May 2023, Senior Judge Preska then handed the SEC an incredibly rare defeat on its motion for summary judgment on its theory that their client had violated Sections 5(a) and 5(c) of the Securities Act of 1933 (“Securities Act”).  These events provided the foundation for a recent favorable resolution for their client.

Section 5(a) and 5(c) of the Securities Act make it unlawful to offer or sell a security in interstate commerce unless a registration statement has been filed or the transaction qualifies for an exemption from registration.  Section 5 is a strict liability statute; the SEC is not required to prove scienter.  Consequently, degrees of fault, negligence and intent are irrelevant to determining liability.  Moreover, Section 5 does not limit liability to the initial distribution of securities, and liability under the statute extends to participants in the sale who were both necessary for the transaction and a substantial factor in bringing it about.

The SEC alleged that SRFC’s client, through related entities, had obtained unrestricted shares of two publicly-traded companies and then caused those shares to be sold into the market without any exemption from the registration requirements of the federal securities laws.  A significant part of the SEC’s case relied on the acts and testimony of a convicted, serial fraudster, Zirk de Maison, who was already serving more than twelve (12) years in prison and had been ordered to pay in excess of $39,000,000 in restitution for his role in an unrelated massive, penny-stock scheme.  Mr. de Maison sought cooperation credit from the U.S. Attorneys for the Northern District of Ohio as well as the SEC, and in that context, the SEC built its lawsuit against the defendants.

Mr. Ference said, “Federal courts often defer to the SEC’s allegations at the pleading stage of an enforcement action, and follow a long line of cases that have, on lesser fact allegations, allowed SEC cases to go forward based on inferences of scienter that is below what many private litigants must show in civil litigations that do not involve the SEC.  The SEC, however, is not a typical civil litigant.  Its pre-action investigatory powers and tools have no analog in ordinary civil litigation.  The SEC has the resources and discretion to expand its investigatory focus, to abandon its prior theories and to saddle anyone in the SEC’s focus – even when the SEC lacks any focus whatsoever – with unprecedented and often-crippling costs: legal, financial and reputational.  It’s simply extremely difficult and expensive to fight for fairness and to defeat the SEC when the pre-action investigation can drag on for years before a lawsuit even starts.  Few individuals and entities in the United States have the resources and resolve to fight and the right attorneys to stand by them and fight for every fact and every win.”

The SEC alleged that Magna’s founder was individually liable for violating Section 17(a) of the Securities Act and Section 10(b) of the Securities Exchange Act of 1934 (“Exchange Act”) and Rule 10b-5 thereunder and Section 20(a) of the Exchange Act.  The Court, however, rejected each of the SEC’s claims as a matter of law.  SRFC’s client was the only defendant to win dismissal on these claims.  

Following years of extensive and contentious fact discovery, in May 2023, Judge Preska issued an eighty-six page Opinion and Order that, in relevant part, handed the SEC an incredibly rare summary judgment loss on its Section 5 claim against the founder after crediting the “conflicting nature of the evidence” developed and presented by SRFC.  Under the circumstances, the Court concluded that there was a “genuine dispute of material fact” as to whether the founder was a “necessary participant and substantial factor” in the unregistered securities sales.

 “From the outset, we told the SEC that this was an extraordinary overreach to bring an enforcement action against the founder that was not supported by facts but was, in large part, premised upon the self-serving claims of a convict.  Almost no one has the emotional and financial reserves to fight for that long.  Still, although delayed, justice was not denied.  We are especially gratified that Judge Preska’s detailed analysis presents a “roadmap” of what is demanded to deny the SEC judgment on Section 5 liability.  This was the right result.”

The SEC’s lawsuit was recently resolved with no determinations of fraud, control person liability, Section 5 liability, penalties, penny stock bar or joint and several liability against Magna’s founder.  

SEC v. Magna Equities II, LLC, 433 F.Supp.3d 496 (S.D.N.Y. Jan. 14, 2020); SEC v. Magna Equities II, LLC, No. 1:19-cv-01459 (LAP), 2023 WL 3260032 (S.D.N.Y. May 4, 2023).

Sichenzia Ross Ference Carmel LLP is a full-service law firm with a nationally-recognized corporate, securities and litigation practice that provides experienced representation in all matters involving the securities industry.  In addition to handling routine to complex commercial matters, SRFC’s litigation practice specializes in representing public and private companies, private funds, investment banks, broker-dealers, investment advisers, placement agents, directors and officers, special committees, and corporate and individual investors in securities and commercial litigation, arbitration, regulatory actions and enforcement defense, including class action lawsuits, shareholder derivative actions, and matters involving allegations of fraud, misrepresentation or other securities violations.  The firm complements its core practice areas with an established tax, commercial real estate and trusts and estates practice.

Sichenzia Ross Ference Carmel LLP Represents Siyata Mobile in a $4 Million Public Offering

siyata mobile logo

New York, NY – May 8, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it has represented Siyata Mobile Inc. (Nasdaq: SYTA) (Nasdaq: SYTAW) (“Siyata” or the “Company”), a global developer and vendor of Push-to-Talk over Cellular (PoC) handsets and accessories, in a public offering of $4.0 million of common shares, and/or pre-funded warrants to purchase common shares at a public offering price of $1.30 per share.

​​Spartan Capital Securities, LLC acted as the sole placement agent in connection with the offering.

The SRFC team was led by partners Ross Carmel, Thiago Spercel and associate Mohit Agrawal.

Sichenzia Ross Ference Carmel LLP Represents INmune Bio Inc. in $9.7 Million Registered Direct Offering

inmunebio logo

Press Release – New York, NY – April 29, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, in approximately $9.7 million registered direct offering of 986,000 shares of its common stock and warrants to purchase up to an aggregate of 986,000 shares of its common stock. Maxim Group LLC acted as the sole placement agent for the offering

The Sichenzia Ross Ference Carmel LLP team was led by partners Marc J. Ross, Thomas Rose, David Manno, Matt Siracusa and law clerk Soumya Cheedi.

Founding Partner Gregory Sichenzia Discusses the Rubrik IPO with Law360

Press Release – New York, NY – April 29, 2024 – Gregory Sichenzia, founding partner at Sichenzia Ross Ference Carmel LLP, recently spoke with Law360 and was quoted in the resulting article entitled, Rubrik Leads Trio Of IPOs That Buoy Recovering Market. 

Sichenzia noted that AI has improved capital raising prospects for smaller and mid-sized companies, such as the Serve Robotics uplisting that SRFC recently advised on. He is later quoted in the article as saying, “there’s a lot of money on the sidelines because the market (IPO) was quiet for so long. There’s a bigger appetite now.”

Sichenzia Ross Ference Carmel LLP Represents INmune Bio Inc. in $4.8 Million Registered Direct Offering

inmunebio logo

Press Release – New York, NY – April 24, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, in approximately $4.8 million registered direct offering of its common sale and purchase of 571,592 shares of its common stock  and warrants to  purchase 571,592 shares of its common stock.

The Sichenzia Ross Ference Carmel LLP team was led by partners Marc J. Ross, Thomas Rose, David Manno, Matt Siracusa and associate Soumya Cheedi.

CLIENT ALERT: What you need to know about the FTC’s Historic Ban on Non-competes

Highlights:

  • For-profit, public and non-public employers, existing non-competes with senior executives remain enforceable. Employers must notify all other employees that existing non-competes are unenforceable by the effective date.
  • Employers are prohibited from entering into new non-competes with all employees, including senior executives, after the effective date.
  • The Final Rule becomes effective 120 days after publication in the Federal Register.

Background:

On April 23, 2024, the Federal Trade Commission (“FTC”) issued its Final Rule banning retroactively almost all non-competes nationwide, across all business sectors, most business entity forms and for both public and non-public companies. Acting on an Executive Order issued by the Biden Administration in July 2021, the FTC was tasked to “exercise the FTC’s statutory rulemaking authority under the Federal Trade Commission Act to curtail the unfair use of non-compete clauses and other clauses or agreements that may unfairly limit worker mobility.” The Final Rule will not take legal effect until 120 days from its publication in the Federal Register (“Effective Date”).  Consequently, the Final Rule has no current legal effect on existing non-competes until the Effective Date.

With respect to existing non-competes in contracts, the Final Rules takes two different approaches for “senior executives” and all other employees. Existing non-competes with senior executives remain effective and enforceable. As to all other employees, the Final Rule provides that existing non-competes promote an “unfair method of competition” and are no longer unenforceable. As to the latter, absent good faith, it would be a violation of the Final Rule “to enter into or attempt to enter into a non-compete clause; to enforce or attempt to enforce a non-compete clause; or to represent that the worker is subject to a non-compete clause.”

The Final Rule also provides that, with respect to “senior executives” who enter into contracts containing a non-compete term or clause after the Effective Date, it would also be a violation of the Final Rule to “to enter into or attempt to enter into a non-compete clause; to enforce or attempt to enforce a non-compete clause; or to represent that the worker is subject to a non-compete clause.” The Final Rule prohibits all other employees from entering into non-competes after the Effective Date.

The scope of the Final Rule is unprecedented, but still requires a fact-intensive review for both employers and employees to determine who may or may not be covered by the Final Rule once effective.

The Final Rules defines a “senior executive” to be a worker who:

  • “was in a policy-making position (for any part of the preceding year); and
  • received from a person for the employment:
  • total annual compensation of at least $151,164 in the preceding year[1]; or
  • total compensation of at least $151,164 when annualized if the worker was employed during only part of the preceding year; or
  • total compensation of at least $151,164 when annualized in the preceding year prior to the worker’s departure if the worker departed from employment prior to the preceding year and the worker is subject to a non-compete clause.”

The Final Rules defines a “policy-making position” as follows:

[A] business entity’s president, chief executive officer or the equivalent, any other officer of a business entity who has policy-making authority, or any other natural person who has policy-making authority for the business entity similar to an officer with policy-making authority. The definition of ‘policy-making position’ further states that an officer of a subsidiary or affiliate of a business entity that is part of a common enterprise who has policy-making authority for the common enterprise may be deemed to have a policy-making position for the business entity for purposes of this paragraph.

As used in the definition of “policy-making position,” an “officer” is a “president, vice president, secretary, treasurer or principal financial officer, comptroller or principal accounting officer, and any natural person routinely performing corresponding functions with respect to any business entity whether incorporated or unincorporated.” Further, “[t]o account for differences in the way business entities may use and define job titles, the definition includes workers in equivalent roles. By incorporating this definition of ‘officer,’ ‘senior executive’ applies to workers at the highest levels of a business entity.”

Of note, the Final Rule’s “officer” definition is nearly identical to the Securities and Exchange Commission’s definition of “officer” as set forth in its Rule 3b-7.[2]” There are some noteworthy differences. First, the Final Rule’s term “chief executive officer or the equivalent” is intended to be given an expansive (not limiting) interpretation to “to reflect the wider range of businesses with various structures that are subject to the final rule.” Thus, the FTC favors a focus on anticompetitive effects over business formation types. Second, the Final Rule extends to non-public companies, whereas SEC Rule 3b-7 does not. Third, unlike SEC Rule 3b-7, the Final’s Rule’s definition of “policy-making position” does not include the phrase “any vice president of the registrant in charge of a principal business unit, division or function (such as sales, administration or finance)” in the definition of “executive officer.” The FTC’s removal of employees who hold the title of vice president from the definition of “executive officer” is intentional. The FTC takes the position that there is a “broader array” of non-public business entity forms that employ “workers who, despite their titles, are among those who are likely to be coerced or exploited by non-competes.” More specifically, “the only group of workers that is likely to have bargained for meaningful compensation in exchange for their non-compete is senior executives who are both highly paid and, as a functional matter, exercise the highest levels of authority in an organization.”

The Final Rule also speaks to employees who may hold a “senior executive” position in a subsidiary or affiliate business that is part of larger “common enterprise.” The Final Rule excludes from the definition of “senior executive” an employee with “policy-making authority over only a subsidiary or affiliate of a common enterprise who do not have policy-making authority over the common enterprise.” In other words, if the employee does not have “policy-making authority with respect to the common enterprise as a whole, not just a segment of it,” the employee will not be treated as a “senior executive” as to whom the Final Rule does not apply. The FTC reasons as follows:

Workers who head a subsidiary or affiliate of a common enterprise are similar to department heads; the senior executives controlling the entire common enterprise control those individual subsidiaries and affiliates. As the Commission has explained, the Commission finds that department heads and other highly paid non-senior executives do not have sufficient bargaining power to avoid exploitation and coercion and are unlikely to have bargained in connection with non-competes.[3]

The Final Rule does not apply to non-competes entered into by a person pursuant to a bona fide sale of a business entity.

In addition, the Final Rule does not apply where a cause of action related to a breach of a non-compete accrued prior to the Effective Date. Thus, it does not apply where an employer commences an action for violation of a non-compete if the alleged breach occurred prior to the Effective Date.

Again, the Final Rule will not take legal effect until 120 days from the publication of the Final Rule in the Federal Register. Consequently, the Final Rule has no current legal effect on existing non-competes until the Effective Date. Once effective, however, employers must provide employees with existing non-competes notice that they are no longer enforceable. The Final Rule includes proposed, model notice language that may be provided to employees on paper, by mail, by email, or by text.

Once the Final Rule is effective, employers or employees may report information on a suspected violation of the Final Rule to the Bureau of Competition. The Final Rule, however, does not itself create a private right of action. Likewise, it does not preempt State statutes, regulations, orders or interpretations thereof, including with respect to State antitrust, consumer protection and common law. The FTC’s position is that States may continue to enforce their own laws so long as such activities do not conflict with the Final Rule (even if the State statutes, regulations, orders or interpretations thereto, are narrower than the scope of the Final Rule).

On April 24, 2024, the United States Chamber of Commerce, together with a coalition of other interests, filed a lawsuit captioned, Chamber of Commerce of the United States of America v. Federal Trade Commission, Case No. 6:24-cv-00148, in the United States District Court for the Eastern District of Texas, Tyler Division. The lawsuit seeks both declaratory and injunctive relief challenging the Final Rule, including the FTC’s position that “individual noncompete agreements [are] ‘unfair methods of competition’ under the FTC Act” and the position that the FTC Act grants the FTC broad rulemaking authority for “unfair methods of competition.”

According to the lawsuit, “Congress has never empowered the Commission with general rulemaking authority regarding matters under its jurisdiction.” The lawsuit also challenges the retroactive rulemaking effect or result of the Final Rule, as not authorized under the FTC Act.

In anticipation of a legal challenge to the Final Rule, the Final Rule also articulates the position of the FTC that, absent a “judicial ruling on the validity” of the Final Rule, compliance is mandatory upon the Effective Date.

Takeaways

For-profit, public and non-public employers covered by the Final Rule should immediately start to review their own hiring and retention policies and procedures, employee handbooks and manuals, contracts and offers in anticipation of a potentially unprecedented change in the employer-employee landscape across all sectors and wherever employers and employees work. Without regard to any delay in the implementation of the Final Rule, in whole or in part, employers and employees should begin preparing for the possibility that non-competes may be prohibited across the United States for all but a small percentage of senior executives.

For more information and guidance on the FTC’s Final Rule relating to non-competes, and its potential impact on your business or your employment, contact Daniel Scott Furst or another member of Sichenzia Ross Ference Carmel’s Business Litigation & Arbitration, Broker-Dealer Regulation and Compliance Groups.

About The Author

daniel scott furst

Scott Furst is a member of Sichenzia Ross Ference Carmel’s Business Litigation & Arbitration, Broker-Dealer Regulation and Compliance Groups. He has extensive civil litigation, regulatory action, investigations and enforcement defense experience with a specialization in securities, business, complex commercial litigation and employment matters involving senior executives, including with regard to contract disputes, investor, shareholder and member disputes, covenants litigation and statutory discrimination claims, in state and federal courts, before the Securities and Exchange Commission, Financial Industry Regulatory Authority, American Arbitration Association, and JAMS. Mr. Furst also routinely advises, negotiates and drafts employment and transactional agreements for senior executives across all business sectors, including officers and investors in the fund structure and formation space for private equity funds, hedge funds, real estate funds and hybrid vehicles for alternative investments.

[1] “Total annual compensation” is defined to include “salary, commissions, nondiscretionary bonuses and other nondiscretionary compensation earned during that 52-week period. Total annual compensation does not include board, lodging and other facilities as defined in 29 CFR 541.606, and does not include payments for medical insurance, payments for life insurance, contributions to retirement plans and the cost of other similar fringe benefits.”

[2] 17 CFR 240.3b-7 (“The term executive officer, when used with reference to a registrant, means its president, any vice president of the registrant in charge of a principal business unit, division or function (such as sales, administration or finance), any other officer who performs a policy making function or any other person who performs similar policy making functions for the registrant. Executive officers of subsidiaries may be deemed executive officers of the registrant if they perform such policy making functions for the registrant.”)

[3] The Final Rule provides that, “[t]o be considered a ‘common enterprise’ for the purposes of defining policy-making authority and policy-making position, the Commission looks beyond legal corporate entities to whether there is a common enterprise of ‘integrated business entities.’ This means that the various components of the common enterprise have, for example, one or more of the following characteristics: maintain officers, directors, and workers in common; operate under common control; share offices; commingle funds; and share advertising and marketing.”

 

Sichenzia Ross Ference Carmel LLP Represents Alternus Clean Energy, Inc. in a $2.16 Million Private Placement

New York, NY – April 24, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Alternus Clean Energy, Inc. (NASDAQ: ALCE) (“Alternus” or the “Company”), a transatlantic clean energy independent power producer, in the closing of a $2.16 million private placement of convertible notes and warrants. 

The investment is in the form of a Senior Unsecured Original Issue 8% Discount Convertible Note, resulting in proceeds before expenses to Alternus of $2.0 million.

Maxim Group LLC acted as the exclusive placement agent for the private placement.

The SRFC team was led by partners Ross Carmel, Jeff Wofford and associate Mohit Agrawal.

Sichenzia Ross Ference Carmel LLP Represents Genetic Technologies Limited in a $2 Million Registered Direct Offering and Concurrent Private Placement

genetic technologies logo

New York, NY – April 22, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”) in a $2 million registered direct offering and private placement.

The Company issued an aggregate of 1,000,000 American Depositary Shares (“ADSs”) (or ADS equivalents in lieu thereof), each representing 30 ordinary shares of the Company, at an offering price of $2.00 per ADS. In addition, the Company has issued unregistered warrants to purchase up to 1,000,000 ADSs. The warrants have an exercise price of $2.00 per ADS, are exercisable upon issuance and will expire five years following issuance.

The Sichenzia Ross Ference Carmel LLP team was led by partners Darrin M. Ocasio and Avital Perlman and associate Mayank Pradhan.

Sichenzia Ross Ference Carmel LLP Represents Craft Capital Management LLC and R.F. Lafferty & Co. in a $4.2 Million Initial Public Offering and Nasdaq Listing of Mingteng International Corporation

mingten international logo

New York, NY – April 22, 2024 – Sichenzia Ross Ference Carmel LLP (SRFC) today announced that it represented Craft Capital Management LLC and R.F. Lafferty & Co. in an initial public offering of Mingteng International Corporation Inc. (the “Company” or “Mingteng International”), an automotive mold developer and supplier in China. The pricing of its initial public offering includes 1,275,000 ordinary shares, 1,050,000 of which are being offered by the Company and 225,000 by a selling shareholder, at a public offering price of US$4.00 per ordinary share. The ordinary shares have been approved for listing on the Nasdaq Capital Market. 

The SRFC team was led by partners Ross Carmel, Phil Magri and associate Tong Wu. 

Sichenzia Ross Ference Carmel LLP Represents EF Hutton LLC in a $2 Million Common Stock Offering of NRx Pharmaceuticals, Inc.

NRX pharmaceuticals logo

New York, NY – April 22, 2024 – Sichenzia Ross Ference Carmel LLP (SRFC) announced that it represented EF Hutton LLC as the sole book-runner in a public offering of NRx Pharmaceuticals, Inc. (“NRx Pharmaceuticals” or the “Company”), a clinical-stage biopharmaceutical company. The pricing of its underwritten public offering of shares of its common stock are at a public offering price of $3.30 per share, for aggregate gross proceeds of approximately $2.0 million, prior to deducting underwriting discounts and other offering expenses.

The SRFC team was led by partners Ross Carmel, Avital Perlman and associate Christian Lichtenberger.

Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in $40 Million Common Stock Offering and Nasdaq Uplisting of Serve Robotics Inc.

serve robotics logo

New York, NY – April 22, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Aegis Capital Corp, as the sole book-running manager in a common stock offering and uplisting to Nasdaq of Serve Robotics Inc., a leading autonomous sidewalk delivery company. The offering consisted of 10,000,000 shares of common stock at a price to the public of $4.00 per share, for aggregate gross proceeds of $40 million, prior to deducting underwriting discounts and offering expenses. The offering includes the participation of one of Serve’s largest stockholders and strategic partners, Postmates, LLC, a wholly-owned subsidiary of Uber Technologies Inc (NYSE: UBER).

The SRFC team was led by partners Gregory Sichenzia, Barret DiPaolo, Matthew Siracusa and associate Benjamin Sklar.

Sichenzia Ross Ference Carmel LLP Represents Safety Shot, Inc. in a $5 Million Private Placement

safetyshot logo

Press Release – New York, NY – April 16, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Safety Shot, Inc. (Nasdaq: SHOT), the first patented beverage on Earth that helps people feel better faster by reducing blood alcohol content and boosting clarity, in a $5,000,000 private placement from the issuance of 2,369,668 shares at a price of $2.11 per share.

The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory Sichenzia, Arthur Marcus, and associate Mayank Pradhan.

Sichenzia Ross Ference Carmel LLP Represents A2Z Smart Technologies Corp. in $3.3 Million Registered Direct Offering and $2.4 Million Private Placement 

Press Release – New York, NY – April 3,  2024 –Sichenzia Ross Ference Carmel LLP announced today that it represented A2Z Smart Technologies Corp. (the “Company”), (NASDAQ: AZ)(TSXV: AZ), a global leader of advanced proved-in-use smart cart solutions, in the Company’s $3.3 million registered direct offering and $2.4 million private placements. 

The Company issued an aggregate of 9,480,500 common shares in the registered direct offering. In addition, the Company has entered into binding agreements with certain investors to issue 6,842,857 common shares in a private placement at a purchase price of $0.35 per share, for gross proceeds of approximately $2.4 million. The private placement is expected to close within 60 days, subject to satisfaction of closing conditions.

The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory Sichenzia and Avital Perlman, law clerk Rohini Sud and associate Benjamin Sklar. 

Sichenzia Ross Ference Carmel LLP Represents Applied UV, Inc. in a $2.76 Million Registered Direct Offering and Concurrent Private Placement

New York, NY – March 29, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it has represented Applied UV, Inc., (NASDAQ: AUVI; AUVIP) (“Applied UV” or the “Company”) in a $2.76 million registered direct and private placement priced at the market under Nasdaq rules.

The transactions are expected to close on or about April 1, 2024.

As a global leading provider of advanced food security, Applied UV is focused on the development and acquisition of technologies that address infection prevention in the healthcare, hospitality, commercial and municipal markets.

The Sichenzia Ross Ference Carmel LLP team was led by partners Ross Carmel, Jeff Wofford, and associate Jeff Hua.

Sichenzia Ross Ference Carmel LLP Represents Verb Technology Company, Inc. in a $9,010,000 At-the-Market (ATM) Offering

verb technologies logo

Press Release – New York, NY –March 29, 2024 – Sichenzia Ross Ference Carmel LLP represented Verb Technology Company, Inc. (NASDAQ: VERB) (“Verb Technology” or the “Company”), in the offering of $9,010,000 shares of the Company pursuant to an At-The Market Issuance Sales Agreement between Ascendiant Capital Markets, LLC, as sales agent, and the Company, as amended. The shares are being offered and sold pursuant to the Company’s registration statement on Form S-3, including the accompanying base prospectus, and a prospectus supplement, as subsequently supplemented.

Verb Technology is a company focused on interactive video-based sales applications. The Company’s MARKET.live, is a popular livestream social shopping platform. 

The Sichenzia Ross Ference Carmel LLP team was led by partners, Gregory Sichenzia and Marcelle S. Balcombe and by senior paralegal, Raquel Vazquez. 

Sichenzia Ross Ference Carmel LLP’s Litigation Partner Owen Kloter Obtains Victory In Federal Court Under Doctrine Of Abstention In $2.1 Million Estate Litigation Claim

New York, NY – March 27, 2024 – Sichenzia Ross Ference Carmel LLP Litigation Partner Owen Kloter obtained a victory for the Firm’s clients in the Southern District of New York under the rarely-invoked Federal Court doctrine of abstention in Conrad v. Fisher et al., a dispute concerning $2.1 million in real estate proceeds relating to an ongoing will and trust contest in the New York County Surrogate’s Court, In re. Will of McDearmon.

The Firm’s clients, a married couple, were the primary beneficiaries under a decedent’s will. They had filed objections to the probate of decedent’s alleged subsequent will in the New York County Surrogate’s Court in June 2021, and later, a petition to invalidate a trust allegedly created by the decedent, both of which would disinherit them if validated. While these disputes and others were proceeding in the Surrogate’s Court, the decedent’s estate sold his Manhattan cooperative apartment to a purchaser for approximately $2.1 million. In July 2021, the parties to the Surrogate’s Court litigation stipulated that the co-op sale proceeds would be held in escrow pending resolution of the various disputes before the Surrogate’s Court, with 50% being held by each party’s attorney.

Despite the existence of the stipulation, the trustee of the alleged trust filed a separate lawsuit in the Southern District of New York in December 2022, alleging claims of conversion and unjust enrichment against the Firm’s clients and seeking a declaratory judgment that the Trust was entitled to possession of all of the co-op sale proceeds; in essence seeking to outmaneuver the pending determinations, and the protections afforded to the defendants, by the Surrogate’s Court with respect to the alleged will and trust.

Although the Southern District determined that it had subject matter jurisdiction to consider the Trustee’s claims, in deciding the defendants’ motion to dismiss, the Court agreed with the defendants’ arguments and refused to exercise that jurisdiction, invoking the rarely-applied Supreme Court doctrine of abstention set forth in Colorado River Water Conservation District v. United States, 424 U.S. 800 (1976). The Southern District’s opinion found that “[t]he questions of state law, the Surrogate’s Court’s ability to protect the parties’ rights, and the risk of piecemeal litigation with inconsistent outcomes, all weigh in favor of this Court abstaining in favor of the Surrogate’s Court proceedings”, and stayed the federal case pending the Surrogate’s determination of the various disputed issues in the ongoing will and trust contest.

Owen Kloter is a partner in Sichenzia Ross Ference Carmel’s Business Litigation & Arbitration Group. He litigates general commercial litigation matters, broker-dealer and insurance broker claims, trust and estate disputes, and real estate disputes, principally in New York, New Jersey, and Connecticut.

Sichenzia Ross Ference Carmel LLP is a full-service law firm with a nationally-recognized corporate, securities and litigation practice that provides experienced representation in all matters involving the securities industry. In addition to handling routine to complex commercial matters, SRFC’s litigation practice specializes in representing public and private companies, private funds, investment banks, broker-dealers, investment advisers, placement agents, directors and officers, special committees, and corporate and individual investors in securities and commercial litigation, arbitration, regulatory actions and enforcement defense, including class action lawsuits, shareholder derivative actions, and matters involving allegations of fraud, misrepresentation or other securities violations. The firm complements its core practice areas with an established tax, commercial real estate and trusts and estates practice.

Sichenzia Ross Ference Carmel LLP Represents Verb Technology Company, Inc. in a $6.6 Million Regulation A Offering of Common Stock of its Common Stock under Regulation A 

verb technologies logo

Press Release – New York, NY –March 26, 2024 – Sichenzia Ross Ference Carmel LLP represented Verb Technology Company, Inc. (NASDAQ: VERB) (“Verb Technology” or the “Company”), in an offering of shares of its common stock (the “Shares”) for aggregate gross proceeds of approximately $6.6 million. The shares were offered at-the-market under Nasdaq rules and pursuant to the Company’s Form 1-A. The Shares were placed through the efforts of the Company’s Chief Executive Officer, Rory Cutaia. The Company did not pay any commissions in connection with the sale of the Shares.

Verb Technology is a company focused on interactive video-based sales applications. The Company’s MARKET.live, is a popular livestream social shopping platform

The Sichenzia Ross Ference Carmel LLP team was led by partners, Marcelle S. Balcombe and Greg Sichenzia and by senior paralegal, Raquel Vazquez.

Sichenzia Ross Ference Carmel LLP Represents EF Hutton in $2 Million Public Offering of AppTech Payments Corp. 

apptech payments corp logo

Press Release – New York, NY – March 26, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented EF Hutton as underwriter in the public offering of AppTech Payments Corp., a pioneering fintech company powering frictionless commerce. The offering consisted of 2,000,000 shares of its common stock at a public offering price of $1.00 per share for aggregate gross proceeds of approximately $2.0 million, prior to deducting underwriting discounts and other offering expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 300,000 shares of common stock at the public offering price per share, less the underwriting discounts to cover over-allotments, if any.

The Sichenzia Ross Ference Carmel LLP team was led by partners Ross Carmel and Jeff Wofford, and law clerk Nishkarsh Jakhar.

Sichenzia Ross Ference Carmel LLP Represents Beyond Air in $16.0 Million Registered Direct Offering

beyond air logo

Press Release – New York, NY – March 22, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Beyond Air, Inc. (NASDAQ: “XAIR”), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions, in a securities purchase agreement whereby the investors have agreed to purchase 9,638,556 shares of the Company’s common stock and warrants to purchase up to an aggregate of 9,638,556 shares of common stock at a purchase price of $1.66 per share and accompanying warrant in a registered direct offering priced at-the-market under Nasdaq rules. 

Roth Capital Partners and Laidlaw & Company (UK) Ltd. acted as co-placement agents for the offering.

The securities in the offering described above are being offered by the Company pursuant to an effective “shelf” registration statement on Form S-3 (File No. 333-262311) previously filed with the U.S. Securities and Exchange Commission (the “SEC”), which was declared effective on February 1, 2022

The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory Sichenzia and Avital Perlman and associate Soumya Cheedi.

Sichenzia Ross Ference Carmel LLP Represents ShiftPixy, Inc. in $5.0 Million Public Offering

shiftpixy logo

Press Release – New York, NY – March 22, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented ShiftPixy, Inc. (NASDAQ: PIXY), a Florida-based national staffing enterprise, in a $5.0 million public offering. The offering consisted of 590,000 shares of common stock, pre-funded warrants to purchase up to 586,470 shares of common stock, and common warrants to purchase up to 1,176,470 shares of common stock. The offering price was $4.25 per share and accompanying common warrant, or $4.2499 per pre-funded warrant and accompanying common warrant. The company received gross proceeds of approximately $5.0 million, before deducting placement agent’s fees and other offering expenses. A.G.P./Alliance Global Partners acted as placement agent in connection with the offering.

The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory Sichenzia and Jeff Cahlon and associate Christian Lichtenberger.

Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in $6 Million Public Offering of C3is Inc.

c3is logo

Press Release – New York, NY – March 20th, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Aegis Capital Corp. as underwriter, in its public offering of C3is Inc. (the “Company” or C3is”).

The now-closed offering consisted of 120,000,000 Units, each containing one share of common stock or Pre-Funded Warrant. The above offering resulted in gross proceeds to the Company of approximately $6.0 million, before deducting underwriting discounts and other estimated expenses payable by the Company. 

C3is is an international shipping transportation company, providing dry bulk and crude oil tanker seaborne services. Their clientele includes major national and private industrial users, commodity producers, and traders.

The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory SichenziaDarrin M. Ocasio, and Jeff Cahlon, and associate Christian Lichtenberger.

Partner Ross Carmel Quoted in Law360 about Reddit’s Upcoming IPO

Press Release – New York, NY – March 20, 2024 – Ross Carmel, partner at Sichenzia Ross Ference Carmel LLP, was quoted in a recent article published by Law360 entitled, 4 Things To Watch In Reddit’s Coming IPO

Ross’ insights shed light on the shifting landscape of tech IPOs, particularly addressing the cautious investor sentiment reflected in Reddit’s valuation adjustments. His expertise highlights the broader implications for venture-backed technology startups navigating post-boom market realities, making this an insightful piece for anyone interested in the dynamics of initial public offerings and the evolving tech sector.

Carmel Law360

Sichenzia Ross Ference Carmel LLP Represents Worksport Ltd. in $2.8 Million Public Offering

Worksport Ltd. logo
Press Release – New York, NY – March 19, 2024 – Sichenzia Ross Ference Carmel LLP represented Worksport Ltd. – a Company that through its subsidiaries designs, develops, manufactures, and owns the intellectual property on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries – in a registered direct offering and concurrent private placement.

The offering consisted of 3,850,132 shares of common stock (or pre-funded warrants to purchase shares of common stock in lieu thereof) in a registered direct offering. In a concurrent private placement, the Company also agreed to issue and sell to the investor warrants to purchase up to 7,700,264 shares of common stock. The combined effective offering price for each share of common stock (or pre-funded warrant in lieu thereof) and accompanying warrant is $0.74, priced at-the-market under Nasdaq rules.

The Sichenzia Ross Ference Carmel LLP team was led by partners Ross Carmel and Phil Magri, as well as counsel Jeffrey Hua.

Sichenzia Ross Ference Carmel LLP Represents Nature’s Miracle, Inc. in Business Combination with Lakeshore Acquisition II Corp.

nature's miracle inc. logo

Press Release – New York, NY – March 15, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Nature’s Miracle, Inc. (NASDAQ: NMHI) (“Nature’s Miracle” or the “Company”) as special securities counsel in the successful completion of its previously announced business combination with Lackeshore Acquisition II Corp. The combined public company has been renamed “Nature’s Miracle Holding Inc.” The common stock of the combined company began trading on the Nasdaq Global Market on March 11, 2024, under the ticker symbol “NMHI” and the Company’s warrants began trading on the Nasdaq Capital Market on March 11, 2024, under the ticker symbol “HMHIw”. Nature’s Miracle is a growing Controlled Environment Agriculture (CEA) technology company. 

Partner David Manno commented, “We congratulate Nature’s Miracle on the completion of their business combination and Nasdaq listing.” 

The Sichenzia Ross Ference Carmel LLP team was led by partners Huan Lou and David Manno and associate Mayank Pradhan.

 

Nature's Miracle Bell Ringing

Sichenzia Ross Ference Carmel LLP Represents WallachBeth Capital in a $2.5 Million Public Offering

bio affinity

Press Release – New York, NY – March 11, 2024 – Sichenzia Ross Ference Carmel LLP represented WallachBeth Capital in a registered direct offering and concurrent private placement of bioAffinity Technologies, a company addressing the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and broad-spectrum cancer treatments. WallachBeth Capital acted as sole placement agent for the Offering. 

The offering consisted of 1,600,000 shares of common stock in a registered direct offering and common warrants to purchase up to 1,600,000 shares of common stock in a concurrent private placement (together with the registered direct offering) at a combined purchase price of $1.5625 per common share. The common warrants issued pursuant to the concurrent private placement will have an exercise price of $1.64 per share.

The Sichenzia Ross Ference Carmel LLP team was led by partners Ross Carmel and Jeffrey Wofford, as well as law clerk Soumya Cheedi

Sichenzia Ross Ference Carmel LLP Represents ThinkEquity LLC and Laidlaw & Company (UK) Ltd. in a $2.1 Million underwritten Public Offering

oragenics logo

Press Release – New York, NY –March 1, 2024 – Sichenzia Ross Ference Carmel LLP represented ThinkEquity LLC and Laidlaw & Company (UK) Ltd. in an underwritten public offering of Oragenics Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal nanoparticle pharmaceuticals for the treatment of neurological disorders. The offering consisted of 1,400,000 shares of common stock at $1.50 per share for aggregate gross proceeds of approximately $2,100,000, prior to deducting underwriting discounts and other offering expenses. In addition, the Company granted the underwriters a 45-day option to purchase up to an additional 210,000 shares of common stock. The offering closed on March 1, 2024.

The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory Sichenzia, Marcelle S. Balcombe, Jeff Cahlon and Senior Paralegal, Raquel Vasquez

Founding Partner Gregory Sichenzia Quoted in TechTarget on Elon Musk Suing OpenAI for Breach of Contract

Press Release – New York, NY – March 4, 2024 – Gregory Sichenzia, founding partner of Sichenzia Ross Ference Carmel LLP, was quoted in a recent piece published by TechTarget entitled, Elon Musk sues Sam Altman, OpenAI for breach of contract.

Greg is quoted multiple times throughout the article, asserting that while he can’t predict the outcome of the lawsuit, it’s entirely likely a court will hear it. He adds:

“For OpenAI to be coopted by Microsoft might be a very dangerous thing for everybody,” he said. “That’s what Elon Musk is saying. If you get a judge or a court that was sympathetic to that, I think they may hear it.”

Founding Partner Gregory Sichenzia Quoted in US News and World Report Article on the IPO Market

Press Release – New York, NY – March 1, 2024 – Gregory Sichenzia, founding partner of Sichenzia Ross Ference Carmel LLP, was quoted in a recent piece published by US News and World Report entitled, 7 Recent and Upcoming IPOs to Watch in 2024.

Greg is the first expert source quoted in the article, and answered the following when asked to describe the most important factor facing the IPO market today:

“The biggest factors facing the IPO market right now are interest rates and the success of the slew of IPOs planned for the first quarter of 2024,” says Gregory Sichenzia, founding partner at Sichenzia Ross Ference Carmel, a New York City-based securities law firm. “While it’s taken the Fed longer to start slashing interest rates (than) expected, the general consensus is still that the economy is very good and that interest rates will fall sooner rather than later.”

Sichenzia Ross Ference Carmel in US News and World Report

Sichenzia Ross Ference Carmel LLP Represents EF Hutton LLC in $1.5 Million Underwritten Public Offering of NRx Pharmaceuticals

NRX pharmaceuticals logo

Press Release – New York, NY –February 28, 2024 – Sichenzia Ross Ference Carmel LLP represents EF Hutton LLC in $1.5 million underwritten public offering of NRx Pharmaceuticals (the “Company”) (Nasdaq: NRXP), a clinical-stage biopharmaceutical company. The offering consisted of $0.30 per share, for aggregate gross proceeds of approximately $1,500,000, prior to deducting underwriting discounts and other offering expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 750,000 shares of common stock (or pre-funded warrants in lieu thereof). The offering is expected to close on February 28, 2024, subject to satisfaction of customary closing conditions. 

The Sichenzia Ross Ference Carmel LLP team was led by partners Ross Carmel, Avital Perlman, and associate Christian Lichtenberger.

Sichenzia Ross Ference Carmel LLP Represented Vocodia Holdings Corp. In $5.95 Million Initial Public Offering on the BZX Exchange of CBOE Global Markets

vocodia holdings Ltd logo

Press Release – New York, NY – February 22, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Vocodia Holdings Corp. (the “Company”), an AI software company, in a $5.95 million initial public offering, the inaugural initial public offering on the BZX Exchange of CBOE Global Markets. The offering consisted of 1,400,000 Units (collectively the “Units” or “Unit”), each consisting of one share of Common Stock of the Company, par value $0.0001 (“Common Stock”), one Series A Warrant to purchase one share of Common Stock at $4.25 (the “Series A Warrant”), and one Series B Warrant to purchase one share of Common Stock at $8.50 (the “Series B Warrant”), at a price to the public of $4.25 per Unit (the “Public Offering Price”). The gross proceeds from the offering are approximately $5,950,000.

The Sichenzia Ross Ference LLP team was led by partners Ross Carmel, Thiago Spercel, and associate Chance Moore.

Sichenzia Ross Ference Carmel LLP Represents ThinkEquity LLC in $7.75 Million Initial Public Offering of Common Stock of Cel-Sci Corp.

Press Release – New York, NY – February 21, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented ThinkEquity LLC in the initial public offering of the common stock of Cel-Sci Corp. (NASDAQ: CVM) (the “Company”), a phase 3 cancer immunotherapy company. The offering consisted of 3,875,000 shares of the Company’s common stock at a public offering price of $2.00 per share, for gross proceeds of approximately $7.75 million. The securities will be offered and sold pursuant to a shelf registration statement on Form S-3 (File No. 333-265995), including a base prospectus, filed with the U.S. Securities and Exchange Commission (the “SEC”) on July 1, 2022 and declared effective on July 15, 2022. 

The Sichenzia Ross Ference Carmel LLP team was led by partners Ross Carmel, Phil Magri, and counsel Jeffrey Hua.

Sichenzia Ross Ference Carmel LLP Represents Lexaria Bioscience Corp. in a $3.6 Million Registered Direct Offering  

lexaria bioscience logo

Press Release – New York, NY – February 16, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Lexaria Bioscience Corp. (the “Company”), (NASDAQ: LEXX), a global innovator in drug delivery platforms, in a $3.6 million registered direct offering priced at-the-market under Nasdaq rules. The deal consists of 1,558,443 shares of common stock (or common stock equivalents in lieu thereof) at a purchase price of $2.31 per share (or per common stock equivalent in lieu thereof). In a concurrent private placement, the Company issued unregistered warrants to purchase up to 1,558,443 shares of common stock at an exercise price of $2.185 per share that are immediately exercisable upon issuance and will expire five years following the date of issuance. The gross proceeds to the Company for the offering were approximately $3.6 million. 

The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory Sichenzia and Avital Perlman and associate Christian Lichtenberger.

SEC Rules 3a5-4 and 3a44-2

On February 6, 2024, the Securities and Exchange Commission adopted new Rules 3a5-4 and 3a44-2 (“Final Rules”) that interpret Sections 3(a)(5) and 3(a)(44) of the Securities Exchange Act of 1934 (“Exchange Act”) which provide the definitions of “dealer” and “government securities dealer,” respectively.

For any person that owns or controls at least $50 million in total assets and is not a registered investment company, central bank, sovereign entity or international financial institution, if that person engages in the following activities for its own account as part of a regular business, it would be deemed under the Exchange Act as a “dealer” or “government securities dealer:”

  • Regularly expressing trading interest that is at or near the best available prices on both sides of the market for the same security and that is communicated and represented in a way that makes it accessible to other market participants; or
  • Earning revenue primarily from capturing bid-ask spreads, by buying at the bid and selling at the offer, or from capturing any incentives offered by trading venues to liquidity supplying trading interest.

The final rules define “own account” to mean an account: (i) held in the name of that person; or (ii) held for the benefit of that person. With a view to deterring the establishment of multiple legal entities or accounts to evade appropriate regulation, the Final Rules include an anti-evasion provision that prohibits persons from evading the registration requirements by: (1) engaging in activities indirectly that would satisfy the qualitative factors; or (2) disaggregating accounts. Note that there is no requirement in the statutory text of either Section 3(a)(5) or Section 3(a)(44) that dealers have customers.

The Final Rules are not the exclusive means of establishing that a person is a dealer or government securities dealer; otherwise applicable SEC interpretations and precedent will continue to apply.

Other commentators note that: “Hedge funds and other [proprietary trading funds] PTFs that use high-volume trading strategies will need to review this standard and the SEC’s guidance carefully to determine whether their activities will now result in a dealer registration obligation.  The SEC noted in particular that market participants employing “automated, algorithmic trading strategies that rely on high frequency trading strategies to generate a large volume of orders and transactions” would be captured by this standard if they have established themselves as “significant market intermediaries” and “critical sources of liquidity.””

If a client is determined to fall within the definitions, it will be required to:

  • Register with the SEC under Section 15(a) or Section 15C, as applicable;
  • Become a member of a Self Regulatory Organization (i.e., FINRA); and
  • Comply with federal securities laws and regulatory obligations and applicable SRO and Treasury rules and requirements.

The Final Rules will be effective on or about April 8, 2024 (60 days following the date of publication of the adopting release in the Federal Register).

See the Final Rules here: https://www.sec.gov/files/rules/final/2024/34-99477.pdf

See the SEC Fact Sheet here: https://www.sec.gov/files/34-99477-fact-sheet.pdf

Sichenzia Ross Ference Carmel LLP Represents Sunshine Biopharma, Inc. in $10.0 Million Underwritten Public Offering of Common Stock

sunshine biopharma

Press Release – New York, NY – February 15, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Sunshine Biopharma, Inc. (NASDAQ: SBFM), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas, in a $10.0 Million Underwritten Public Offering of common stock. The offering consists of 71,428,571 Units, each consisting of one share of common stock or Pre-Funded Warrant to purchase one share of common stock and 0.1 Series A Warrants to purchase one share of common stock per warrant, and 0.2 Series B Warrants to purchase one share of common stock per warrant. The public offering price per Unit is $0.14 (or $0.139 for each Unit with a Pre-Funded Warrant, which is equal to the public offering price per Unit with a share of common stock to be sold in the offering minus an exercise price of $0.001 per Pre-Funded Warrant). The gross proceeds of the transaction is $10 million. 

The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory Sichenzia, Darrin Ocasio, Jeff Cahlon, and associate Christian Lichtenberger. 

Sichenzia Ross Ference Carmel LLP Represents ToughBuilt Industries, Inc. in $3.5 Million Public Offering of Common Stock 

Press Release – New York, NY – February 15, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented ToughBuilt Industries, Inc. (NASDAQ: TBLT) (the “Company”) in its public offering of common stock. The offering consisted of 772,628 shares of its common stock (or pre-funded warrants in lieu thereof), together with warrants to purchase up to 772,628 shares of its common stock at an offering price to the public of $4.53 per share (or pre-funded warrant) and associated warrant. The warrants will have an exercise price of $4.405 per share, be exercisable upon issuance, and will expire five years following the date of issuance.

The Sichenzia Ross Ference Carmel LLP team was led by partners Ross Carmel and Phil Magri.

Sichenzia Ross Ference Carmel LLP Represents Dominari Securities LLC in $5 Million Initial Public Offering of Unusual Machines, Inc.

unusual machines logo

Press Release – New York, NY – February 15, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Dominari Securities LLC in the initial public offering of Unusual Machines, Inc. (the “Company”), an emerging leader in first-person view drone technology. The offering consisted of 1,250,000 shares of common stock at a public offering price of $4.00 per share. The shares are expected to begin trading on the NYSE American on February 14, 2024, under the ticker symbol “UMAC”. The gross proceeds of the offering is $5 million. 

The Sichenzia Ross Ference Carmel LLP team was led by partners Ross Carmel, Brian Margolis, and associate Chance Moore.

Sichenzia Ross Ference Carmel LLP Represents ThinkEquity LLC and Laidlaw & Company (UK) Ltd. in $8 Million Initial Public Offering of Common Stock of Perfect Moment Ltd.

Perfect moment logo

Press Release – New York, NY – February 13, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented ThinkEquity LLC and Laidlaw & Company (UK) Ltd. in the initial public offering of the common stock of Perfect Moment, Ltd. (NASDAQ: PMNT) (the “Company”), a luxury lifestyle brand that combines fashion and technical performance for its ranges of skiwear, outerwear, swimwear and activewear. The offering consisted of 1,334,000 shares of the Company’s common stock at a public offering price of $6.00 per share, for gross proceeds of approximately $8 million. The Company has granted the underwriters a 45-day option to purchase up to an additional 200,100 shares of common stock to cover over-allotments at the public offering price.

The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Barrett DiPaolo and Matthew Siracusa, and associate Christian Lichtenberger.

Sichenzia Ross Ference Carmel LLP Represents Spartan Capital Securities in a $4 Million Public Offering for Inspire Veterinary Partners

Press Release – New York, NY – February 9th, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Spartan Capital Securities, LLC in a $4.0 million public offering of Inspire Veterinary Partners, Inc. (NASDAQ: IVP) (the “Company” or “Inspire”).

Inspire is an employee-owned veterinary organization, focused on bringing more opportunities and fair market value to all veterinarians, whilst also equipping your team with the coaching and resources necessary to accelerate their career in the industry.

The public offering was comprised of 47,058,823 shares of Class A common shares and, at the option of purchasers, pre-funded warrants in lieu of shares, priced at a public offering price of $0.085 for one common share or pre-funded warrant (less the par value of each share of Class A common stock in the case of each pre-funded warrant). The offering is expected to close on February 13, 2024, subject to customary closing conditions. The Company intends to use the net proceeds from this offering for strategic acquisitions, the engagement of external, third-party marketing and business consultants. working capital and general corporate purposes.

The Sichenzia Ross Ference Carmel LLP team was led by partners Ross Carmel and Jeff Wofford, and law clerk Soumya Cheedi.

Click here for a full list of recent transactions headed by SRFC.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

Sichenzia Ross Ference Carmel LLP

Sichenzia Ross Ference Carmel LLP Closes Over 100 Capital Markets Transactions Valued At Over $700 Million in 2023

SRFC further demonstrated its presence by representing organizations on IPOs, public and private offerings, and other market activity in 2023.

New York, NY – February 8th, 2024 – Today, Sichenzia Ross Ference Carmel LLP (“SRFC”), a full-service law firm internationally recognized for its securities and litigation practices, announced that it has closed over 100 transactions, ranging from $1.1 million to $70 million. In 2023, with the total value of these transactions surpassing $700 million. The transactions on behalf of both issuers and underwriters included initial public offerings, secondary public offerings, registered direct offerings and private placements.

SRFC provides world-class, personalized and cost-effective solutions, representing broker-dealers, businesses and individuals in all types of commercial litigation and arbitration. In October of 2023, Sichenzia Ross Ference LLP combined forces with Carmel, Milazzo & Feil to form SRFC and currently consists of approximately 70 experienced attorneys in offices including New York City, California and Florida.

Notable transaction highlights from 2023 include:

“Sichenzia Ross Ference Carmel is proud to be one of the most prolific securities law firms in the country, representing some of the most dynamic companies entering the market today,” said Greg Sichenzia, Founding Partner at SRFC. “Expectations are high for 2024, especially for the return of a strong IPO market and participation from global issuers and underwriters. We look forward to growth on behalf of the firm, its people and our clients In our first full year as SRFC.”

A full list of transactions can be found here

About Sichenzia Ross Ference Carmel LLP
SRFC is a full-service law firm with a nationally recognized corporate, securities, and litigation practice that provides experienced representation in all matters involving the securities industry. In addition to handling routine to complex commercial matters, SRFC’s renowned litigation and regulatory department specializes in defending broker-dealers, registered persons, public and private corporations, and individuals in investigations and enforcement proceedings before the SEC, FINRA, and other regulatory bodies, as well as litigations and arbitrations across all forums in the securities industry, including class action lawsuits, shareholder derivative actions, and matters involving allegations of fraud, misrepresentation or other securities violations.

Finally, SRFC has a burgeoning expungement practice, where it represents registered persons seeking to have false and harmful customer complaints removed from their industry records. In addition to SRFC’s well-known securities practice, we have expertise in multiple disciplines including complex commercial litigation in an array of matters from shareholder derivative actions, partnership disputes, breach of contract, etc. SRFC practice groups include tax and trust and estates, notably providing sophisticated estate planning for its high-net-worth clients.

Follow SRFC on LinkedIn and X (formerly Twitter)

Media contact:
FischTank PR
srfc@fischtankpr.com

 

Is The IPO Market Back In Business?

As written by Gregory Sichenzia and originally published by Crunchbase.

It’s difficult to determine who is watching the IPO market closer: investors or startups.

From a high level, the consensus appears to be that with interest rates set to recede at some point in the first half of 2024, coupled with the resiliency of the U.S. economy and recent GDP and inflations numbers, the IPO market is back in business.

Nasdaq CEO Adena Friedman recently explained while at the Consumer Electronics Show that close to 100 companies have recently filed confidentiality with the SEC for initial public offerings and plan to list on Nasdaq — suggesting a major rebound for the IPO market.

But those of us who work with new issuers on a near daily basis know: This IPO market will not be like the ones of the past five years.

Gone are the days where a company could slap “ESG,” “cryptocurrency,” “artificial intelligence” or “EV” on its website and instantly raise tens, if not hundreds, of millions of dollars in private and public offerings.

H1 2024 expectations

Let’s start with some of the drivers and trends beyond just falling interest rates.

First, interest rates don’t just mean “cheap money” for startups and emerging tech companies. They also mean that the CDs and Treasury notes where retail and institutional investors parked their money the past two years will no longer yield 5%-plus. Investors who did so were smart, and they’ll be smart again — meaning it will be time to withdraw those assets and place them elsewhere, creating even more opportunity for issuers and underwriters to attract shareholders.

Further, some of the largest public companies in the world, such as NvidiaMicrosoft and, until a few weeks ago, Tesla, have all thrived lately, placing the market at all-time highs. Investors are happy and will take those same profits and start hunting for high-growth opportunities in IPOs.

Without delving too much into politics, some investors and banks are so convinced that former President Trump will win, they’re placing bets on more deregulated capital markets. There is always a push and pull between Democratic and Republican candidates, with the former advocating for tighter regulations that have the potential to slow capital markets activity, while the latter seeks to create a more friendly environment for issuers and underwriters.

That’s not to say each bank or company raising capital believes this, but it is a constant theme in the market feedback we receive.

The biggest trend we’re seeing in the U.S. IPO market right now is more mature companies seeking to go public. Reddit, a brand that has been around forever and rumored to go public several times, is a prime example. Another is Amer Sports, which makes Wilson tennis rackets, and is targeting a valuation of up to $8.7 billion for its U.S. initial public offering.

Many people, including me, believe this deal will be a bellwether event for the IPO market, and that if successful, we may see a cascade of offerings quickly follow.

Lastly, the U.S. economy’s ability to not just avoid recession but to actually grow is resulting in international companies seeking exposure to U.S. capital markets.

We are seeing this in many regions of the world, particularly Southeast Asia and parts of Europe where revenue-producing, high-growth technology and consumer brands are thriving. Companies there see the U.S. as the right venue for liquidity events, and thus are engaging banks to help them raise capital.

It’s important to remember that all of this can change at any moment. Concern over when interest rates will fall has already led to some volatile trading days and hesitant IPOs in 2024.

I predict we’ll see a number of companies quietly test the waters these next couple months, and that Q2 will be when we really see filings and listings pick up. Until then, stay tuned to Fed guidance, inflation and job reports, and exciting companies seeking exposure in the U.S.’ resilient stock market.

Sichenzia Ross Ference Carmel LLP

Sichenzia Ross Ference Carmel LLP Represents AiAdvertising, Inc. in a $2.5 Million Private Placement

Press Release – New York, NY – February 6th, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented AiAdvertising, Inc. (OTC: AIAD),  an AI-powered solutions provider employing the industry’s scientifically advanced, patent-pending AI targeting process, in a $2,500,000 private placement of Series I Preferred Stock.

AiAdvertising sold 892,857 shares of Series I Preferred Stock at a purchase price of $2.80 per share of Series I Preferred Stock. This was the second tranche of an offering pursuant to a securities purchase agreement entered into between AiAdvertising and Hexagon Partners, Ltd., a Texas based investment company.

The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory Sichenzia, Marcelle Balcombe, and senior paralegal Raquel Vazquez.

Click here for a full list of recent transactions headed by SRFC.

Sichenzia Ross Ference Carmel LLP

Sichenzia Ross Ference Carmel LLP Represents TruGolf, Inc. as Special Securities Counsel in Business Combination with Deep Medicine Acquisition Corp.

TruGolf logo

Press Release – New York, NY – February 6th, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented TruGolf, Inc. (NASDAQ: TRUG) (“TruGolf” or the  “Company”) as special securities counsel in the successful completion of its previously announced business combination with Deep Medicine Acquisition Corp. (“Deep Medicine”). The combination has resulted in TruGolf becoming a publicly-traded company, and the combined public company being renamed “TruGolf Holdings, Inc.”

The common stock of the combined company began trading on the NASDAQ Stock Market (“NASDAQ”) under the new ticker symbol “TRUG” on February 1st, 2024.

“We share TruGolf’s vision of making golf more accessible to a broader and rapidly growing audience,” stated Humphrey Polanen, CEO of DMAQ. “TruGolf’s innovative software and data analytics can improve the players’ skills, while the user-friendly design increases their enjoyment of golf.”

Chris Jones, CEO and Co-Founder of TruGolf, commented, “Today marks a significant milestone as we embark on our journey as a publicly traded company. This is not just a financial achievement, as this will serve as a vehicle to accelerate our growth and a testament to the commitment and expertise of our board, management team and passionate employees. We are thankful for the DMAQ team’s support and guidance throughout the transaction process.”

TruGolf is a sporting company focused on the development of ultra-realistic and precise golf simulators and solutions surrounding golf. Their team has built multiple award-winning video games (“Links”), as well as the hardware solutions to accompany such. They’re passionate about the development of innovative indoor golf solutions and helping the golf industry grow by making golf more accessible, affordable, and available.

Deep Medicine was a special purpose acquisition company formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses or entities. Deep Medicines began trading on the NASDAQ in October 2024 under the ticker “DMAQ” and “DMAQR”, respectively.

The Sichenzia Ross Ference Carmel LLP team was led by partners Arthur Marcus and Matt Siracusa, and law clerk Rohini Sud.

Click here for a full list of recent combinations & transactions headed by SRFC.

This memorandum is provided by Sichenzia Ross Ference Carmel LLP for educational and informational purposes only and is not intended and should not be construed as legal advice. This memorandum is considered advertising under applicable state laws.

Sichenzia Ross Ference Carmel LLP

Sichenzia Ross Ference Carmel LLP Represents BullFrog AI Holdings, Inc. in $5.7 Million Underwritten Public Offering

Press Release – New York, NY – February 1st, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Bullfrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“Bullfrog AI” or the “Company”), in an underwritten public offering of an aggregate of 1,507,139 shares of common stock and accompanying warrants to purchase 1,507,139 shares of common stock at a public offering price of $3.782 per share.

The gross proceeds of the above offering are approximately $5,700,000, prior to deducting underwriting discounts and offering expenses. The Company intends to use the net proceeds from the offering for working capital and other general corporate purposes. The offering is expected to close on February 5, 2024, subject to satisfaction of customary closing conditions.

Bullfrog AI is a digital biopharma company, focused on the use of artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics. Their lead product, a proprietary AI/ML analytics platform, aims to improve the development process and assist in clinical trials through the identification of “high-value data niches and patient subgroups”.

WallachBeth Capital, LLC is acting as sole book-running manager for the offering.

The Sichenzia Ross Ference Carmel LLP team was led by partner Arthur Marcus, counsel Sharon Carroll, and associate Jesse Blue.

Click here for a full list of recent transactions headed by SRFC.

This memorandum is provided by Sichenzia Ross Ference Carmel LLP for educational and informational purposes only and is not intended and should not be construed as legal advice. This memorandum is considered advertising under applicable state laws.

Sichenzia Ross Ference Carmel LLP

New Financial Thresholds For Pre-Merger Notification For 2024 Announced

On January 22, 2024, the Federal Trade Commission (the “FTC”) announced new jurisdictional thresholds for the Hart-Scott-Rodino Act (“HSR”).

The FTC enforces the federal antitrust laws, specifically Sections 1 and 2 of the Sherman Act, 15 U.S.C. §§ 1, 2; Section 5 of the Federal Trade Commission Act, 15 U.S.C. § 45; and Sections 3, 7, and 8 of the Clayton Act, 15 U.S.C. §§ 14, 18, 19.

Pre-Merger Notification Changes. Section 7 of the Clayton Act prohibits mergers and acquisitions where “in any line of commerce or in any activity affecting commerce in any section of the country, the effect of such acquisition may be substantially to lessen competition, or to tend to create a monopoly.”

Remember, unless an exemption applies, the parties to the merger must file with the FTC and the Department of Justice a Premerger Notification Form and pay the filing fee if the transaction meets three tests:

  • the Commerce Test – If either party is engaged in commerce or in any activity affecting commerce;
    (2) the Size of Transaction Test – see chart below; and
    (3) the Size of Person Test – see chart below.

The FTC is required to adjust the thresholds annually based on the change in gross national product. For 2024, the thresholds are:

TEST

THRESHOLD

Size of Transaction

$119.5 Million

Size of Person

$23.9 Million and $239 Million

Transaction Size above which Size of Person Test Does Not Apply

$478 Million

Notification Thresholds

$119.5 Million

$239 Million

$1.195 Billion

25% of stock worth $2.39 Billion

Filing Fee Changes. The FTC also raised the filing fees for the Premerger Notification:

Size of Transaction

Filing Fee

Greater than $119.5 Million but less than $173.3 Million

$30,000.00

At least $173.3 Million but less than $526.5 Million

$105,000.00

At least $536.5 Million but less than $1.073 Billion

$260,000.00

At least $1.073 Billion but less than $2.0 Billion

$415,000.00

At least $2.0 Billion but less than $5.0 Billion

$830,000.00

$5.0 Billion or more

$2,335,000.00

Interlocking Director Changes. Section 8 of the Clayton Act makes it illegal, subject to certain exceptions, for a person to serve as a director or officer for two competing companies when the companies' profits or competitive sales exceed threshold limits. The FTC increased the thresholds so that an interlocking director would be illegal if each company has capital, surplus, and undivided profits aggregating more than $48,559,000 (Section 8(a)(1)), unless one of the companies' competitive sales against the other are less than $4,855,900 (Section 8(a)(2)(A)) or other de minimis exemptions apply (Section 8(a)(2)(B) and (C)).

Penalty Increase. The maximum civil penalty for violations of the HSR increased from $50,120 per day to $51,744 per day.

Effective Dates. The increased HSR thresholds and filing fees will be effective in late February 2024 (30 days after publication in the Federal Register). The increased civil penalties became effective January 10, 2024 for civil penalties assessed after the effective date, including civil penalties for which the associated violation predated the effective date.

See the FTC Press Release: https://www.ftc.gov/news-events/news/press-releases/2024/01/ftc-announces-2024-update-size-transaction-thresholds-premerger-notification-filings

This memorandum is provided by Sichenzia Ross Ference Carmel LLP for educational and informational purposes only and is not intended and should not be construed as legal advice. This memorandum is considered advertising under applicable state laws.

Sichenzia Ross Ference Carmel LLP Represents 60 Degrees Pharmaceuticals in $2.4 Million Public Offering

Press Release – New York, NY – January 30th, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) in its initial public offering of $2.4 Million.

The offering consists of 5,260,901 units (the “Units) at a price to the public of $0.385 per Unit and 999,076 pre-funded units (the “Pre-Funded Units”) at a price to the public of $0.375 per Pre-Funded Unit.

Each Unit consists of one share of common stock and one warrant exercisable for one share of common stock (the “Warrant”). Each Warrant will have an exercise price of $0.4235 per share, be exercisable immediately upon issuance, and expire five years from the date of issuance. Each Pre-Funded Unit consists of one pre-funded warrant exercisable for one share of common stock (the “Pre-Funded Warrant”) and one Warrant identical to the Warrants included in the Units.

60 Degrees Pharmaceuticals, Inc., founded in 2010, specializes in the development and marketing of new medicines for the prevention and treatment of tropical infectious diseases, including those considered neglected by the World Health Organization. In 2018, their lead product ARAKODA, designed to prevent malaria, was approved for use by the US Food and Drug Administration.

WallachBeth Capital LLC is the Sole Bookrunner for the offering.

The Sichenzia Ross Ference Carmel LLP team was led by partners Ross Carmel, Phil Magri, and counsel Jeffrey Hua.

Click here for a full list of recent transactions headed by SRFC.

This memorandum is provided by Sichenzia Ross Ference Carmel LLP for educational and informational purposes only and is not intended and should not be construed as legal advice. This memorandum is considered advertising under applicable state laws.

Sichenzia Ross Ference Carmel LLP

SEC Issues New Cybersecurity Rule, In Effect For December 31st Year End Companies

On July 26, 2023, the Securities and Exchange Commission issued the Final Rule on Cybersecurity Risk Management, Strategy, Governance, and Incident Disclosure (the “Cybersecurity Rule”). The Cybersecurity Rule requires public companies to disclose both material cybersecurity incidents they experience and, on an annual basis, material information regarding their cybersecurity risk management, strategy, and governance.

Companies are just starting to file their Form 10-Ks with their cybersecurity disclosures set forth in new Item 1(c) pursuant to new Regulation SK, Item 106.

New Regulation S-K Item 106 requires registrants to describe their processes, if any, for assessing, identifying, and managing material risks from cybersecurity threats, as well as whether any risks from cybersecurity threats, including as a result of any previous cybersecurity incidents, have materially affected or are reasonably likely to materially affect the registrant. Item 106 also requires registrants to describe the board of directors’ oversight of risks from cybersecurity threats and management’s role and expertise in assessing and managing material risks from cybersecurity threats. (Emphasis mine.)

Foreign private issuers have similar disclosure obligations in new Item 16K of the Form 20-F.

Note that companies are enhancing their cybersecurity Risk Factors along with this new disclosure.

With respect to the annual Form 10-K and Form 20-F cybersecurity disclosures, all registrants (including Smaller Reporting Companies) must provide such disclosures beginning with their annual reports for fiscal years ending on or after December 15, 2023.

The disclosures being filed now touch on the following subjects:

  • Which entities within the company address cybersecurity risk (i.e., the senior management person who heads up the process; the Board of Directors; the Audit Committee, etc.).
  • Whether the company has a cybersecurity risk management policy approved by the Board of Directors (SRFC should be drafting such policies for clients);
  • What the cybersecurity risk management policy covers;
  • How often cybersecurity threats are assessed;
  • How the company manages the risks (e.g., end-user training, layered defenses, identifying and protecting critical assets, strengthening monitoring and alerting, and engaging experts).

See the Final Cybersecurity Rule here: https://www.sec.gov/files/rules/final/2023/33-11216.pdf

See the SEC Fact Sheet here: https://www.sec.gov/files/33-11216-fact-sheet.pdf

See the SEC Small Entity Compliance Guide here: https://www.sec.gov/corpfin/secg-cybersecurity

SEC Issues New SPAC/De-SPAC Rules: A Definitive Guide

On January 24, 2024, the Securities and Exchange Commission (“SEC”) adopted final rules relating to special purpose acquisition companies (“SPACs”). This email just touches on the material aspects of the final rules which consist of 581 pages. You can see the final rule here: https://www.sec.gov/files/rules/final/2024/33-11265.pdf

Definitions:

  • De-SPAC transaction” means a business combination, such as a merger, consolidation, exchange of securities, acquisition of assets, reorganization, or similar transaction, involving a special purpose acquisition company and one or more target companies (contemporaneously, in the case of more than one target company).
  • Special purpose acquisition company means a company that has: (1) indicated that its business plan is to: (i) conduct a primary offering of securities that is not subject to the requirements of Rule 419 under the Securities Act of 1933 (“Securities Act”); (ii) complete a business combination, such as a merger, consolidation, exchange of securities, acquisition of assets, reorganization, or similar transaction, with one or more target companies within a specified time frame; and (iii) return proceeds from the offering and any concurrent offering (if such offering or concurrent offering intends to raise proceeds) to its security holders if the company does not complete a business combination, such as a merger, consolidation, exchange of securities, acquisition of assets, reorganization, or similar transaction, with one or more target companies within the specified time frame; or (2) represented that it pursues or will pursue a special purpose acquisition company strategy.
  • “SPAC sponsor” means any entity and/or person primarily responsible for organizing, directing, or managing the business and affairs of a special purpose acquisition company, excluding, if an entity is a SPAC sponsor, officers and directors of the special purpose acquisition company who are not affiliates of any such entity that is a SPAC sponsor.
  • “Target company” means an operating company, business or assets.

Registered Offerings by SPACs: The new rules cover: (i) the forepart of the registration statement and the prospectus cover page; (ii) a new summary section; and (iii) a new dilution table.

SPAC sponsor; conflicts of interest: The focus is on identifying the SPAC sponsors and their compensation, including: (i) identifying the controlling persons; (ii) the extent to which the SPAC sponsor, its affiliates, and the promoters are involved in other special purpose acquisition companies; (iii) any agreement between the SPAC sponsor and the SPAC, its officers, directors, or affiliates with respect to determining whether to proceed with a de-SPAC transaction; (iv) the nature (e.g., cash, shares of stock, warrants and rights) and amounts of all compensation to be paid and whether any shares have been transferred, surrendered or cancelled; (v) any actual or potential conflicts of interest; and (vi) any fiduciary duties of each officer and director of the SPAC to other companies.

De-SPAC Transactions: The new rules cover: (i) the forepart of the registration statement and the prospectus cover page: (A) whether the SPAC has received an appraisal; (B) whether any material financing transactions that have occurred since the SPAC IPO or will occur in connection with the consummation of the de-SPAC transaction; (C) the compensation to be received in the de-SPAC transaction; and (D) any material conflicts of interest that have or may occur; (ii) a new summary section; and (iii) a new dilution table.

Background of and reasons for the de-SPAC transaction; terms of the de-SPAC transaction; effects: The registration statement must cover, among other things: (i) how the de-SPAC transaction came about; (ii) the material terms of the transaction; (iii) the financing of the transaction; (iv) differences in the rights of the stockholders of the two companies; (iv) the accounting treatment of the transaction; (v) the tax consequences of the transaction; and (vi) any material interests in the de-SPAC transaction or any related financing transaction held by the SPAC sponsor or the SPAC’s officers or directors.

Board determination about the de-SPAC transaction: Requires disclosure of: (i) whether the SPAC Board found the deal advisable and in the stockholders’ best interests; (ii) the factors used by the Board to reach their decision; (iii) whether the de-SPAC transaction is structured so that approval of at least a majority of unaffiliated security holders of the SPAC is required; (iii)  whether the Board has retained an unaffiliated representative to act solely on behalf of unaffiliated security holders for purposes of negotiating the terms of the de-SPAC transaction; and (iv) whether the de-SPAC transaction was approved by a majority of the SPAC board who are not employees.

Reports, opinions, appraisals, and negotiations: Requires disclosure if the SPAC or SPAC sponsor has received any report, opinion (other than an opinion of counsel) or appraisal from an outside party or an unaffiliated representative relating to the fairness and other matters of the de-SPAC transaction, and if so, summarize it.

Tender offer filing obligations: If the SPAC files a Schedule TO  for any redemption of securities offered to security holders, such Schedule TO must provide additional information from the Proxy Rules and the tender offer must be done in compliance with the Issuer Tender Offer Rules.

Projections: If projections are used in the registration statement, the SPAC must disclose their purpose, assumptions used, and whether the target company has approved them, among other things.

Forward Looking Statements: The rules adopt a definition of “blank check company” under the Private Securities Litigation Reform Act (“PSLRA”) that make the safe harbor for forward-looking statements under the PSLRA unavailable for such blank check companies, including SPACs.

Interactive Data File: The disclosure must comply with Rule 405 of Regulation S-T and the EDGAR Filer Manual. This requirement will become effective on or about May 28, 2025 (490 days after publication in the Federal Register).

Shell Company Mergers. The Final Rule also deals with shell company mergers. Under Rule 145a in certain business combination transactions where reporting shell companies, including SPACs, are parties, the combined company will be required to register the deemed sale of its securities to the pre-transaction reporting shell company shareholders at the time of the business combination, unless there is an available exemption. Thus, the target company will be a co-issuer/co-registrant and its directors and officers will have to sign the registration statement and will be subject to liability under the securities laws.

Amendments to Regulation S-X: The final Rules amend financial statement requirements and the forms and schedules filed in connection with business combination transactions involving shell companies (other than business combination related shell companies), including de-SPAC transactions, to align more closely required disclosures about the target company with those required in a Form S-1 or F-1 for an IPO, including: (i) expanding the circumstances in which target companies may report two years, instead of three years, of audited financial statements; and (ii) further aligning the requirements for audited financial statements in these transactions with those required in a registered IPO.

Effective Date: Except as for the IDF rule, the rules become effective on or about May 28, 2024 (125 days after publication in the Federal Register).

See the Fact Sheet here: https://www.sec.gov/files/33-11265-fact-sheet.pdf

See the Press Release here: https://www.sec.gov/news/press-release/2024-8

This memorandum is provided by Sichenzia Ross Ference Carmel LLP for educational and informational purposes only and is not intended and should not be construed as legal advice. This memorandum is considered advertising under applicable state laws.

New Federal Disclosure Requirements for Corporations and Limited Liability Company

What’s New: Starting January 1, 2024, pursuant to the new Federal Corporate Transparency Act (“CTA”) all persons filing for a new non-exempt corporation or limited liability company (“LLC”) in any State (including the District of Columbia or any U.S. Territory) or in any foreign country must also register their “beneficial owners” and “company applicants” with the U.S. Department of the Treasury’s division of Treasury’s Financial Crimes Enforcement Network (“FinCEN”). First reports must be filed within 90 days of the company’s organization. Sichenzia Ross Ference Carmel (“SRFC”) is advising clients to file concurrently upon organization. Any reporting company that was created before January 1, 2024, must file a report no later than January 1, 2025. Please contact your SRFC attorney to schedule your filing this year.

Who is Exempt?: Certain companies regulated by the Securities and Exchange Commission or the
Federal banking agencies are exempt. Check with your SRFC attorney to find out of your company
is exempt from the registration requirement.

What if We Don’t File?: The willful failure to report complete or updated beneficial ownership
information to FinCEN, or the willful provision of or attempt to provide false or fraudulent
beneficial ownership information may result in a civil or criminal penalties, including civil
penalties of up to $500 for each day that the violation continues, or criminal penalties including
imprisonment for up to two years and/or a fine of up to $10,000.
Senior officers of an entity that fails to file a required BOI report may be held accountable for that
failure.

Who is a “Beneficial Owner”?: A beneficial owner is any individual who, directly or indirectly:
• Exercises substantial control over a reporting company; OR
• Owns or controls at least 25 percent of the ownership interests of a reporting company.
Each of the bold faced terms have complex definitions under the regulations. For example,
“substantial control” may include persons “who have substantial influence over important
decisions made by the reporting company…”
“Ownership interests” include equity, profit interests, convertible instruments, and options and the
“catch all” provision.

There are exemptions to the beneficial owner definitions, including minor children, custodians,
employees, inheritors and creditors. To determine who in the company must file as a Beneficial
Owner, please confer with your SRFC attorney.

Who is the “Company Applicant”?: If the company is organized after January 1, 2024, the
individual who is primarily responsible for directing or controlling the filing must file as the
Company Applicant. SRFC believes that to be the incorporator of the corporation, the organizer of
the LLC or member of senior management of the Company who has asked SRFC to assist in the
organization of the company. (There is no Company Applicant for entities formed before January
1, 2024).

What Details Are In The Filing?: Reporting companies must provide:
– Full legal name
– Trade name if any
– U.S. address
– Jurisdiction of formation
– IRS Taxpayer ID number

The Beneficial Owner and the Company Applicant must provide:
– Full legal name
– Date of birth
– Current address
– Image of either passport or driver’s license

How To File: Your filing will be coordinated with your SRFC attorney who will assist with the
preparation of the organization and FinCEN documents in conjunction with a third-party filing
service that will be the “direct applicant” under the CTA. The filing service will charge a separate
fee for filing directly with FinCEN. You can avoid that fee if you wish to file yourself directly on
the FinCEN website.

Updates/Changes Must Be Filed: If there is any change to the required information about the
reporting company, its Beneficial Owners or the Company Applicant in a previously filed report,
the company must file an updated BOI report no later than 30 days after the date on which the
change occurred. If an inaccuracy is identified in a BOI report, the company must correct it no
later than 30 days after the date your company became aware of the inaccuracy or had reason to
know of it.

Your Information Is NOT Publicly Available: These reports are not available to the public (even
through the Freedom of Information Act), but will be accessible by law enforcement at the federal,
state and local levels. Financial institutions may also have access upon their customer’s consent.

Questions? If you have any questions about this new filing requirement, please contact your SRFC
attorney.

This memorandum is provided by Sichenzia Ross Ference Carmel LLP for educational and informational purposes only and is not intended and should not be construed as legal advice. This memorandum is considered advertising under applicable state laws.

Sichenzia Ross Ference Carmel LLP Represents Spartan Capital Securities, LLC in $8.45 Million Private Offering of Alpha Cognition, Inc.

alpha cognition logo

Press Release – New York, NY – January 23rd, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Spartan Capital Securities, LLC., acting as the exclusive placement agent, in the final closing pursuant to its previously announced private placement of Alpha Cognition, Inc. (the “Company”).

The gross proceeds of the offering received to date are US$8.45 million, which includes shares of the fully subscribed 30% overallotment.

Alpha Cognition Inc. is a biopharmaceutical company focused on providing those with neuro-degenerative diseases the support they need to function in daily life. Their recent treatment options include the impressive ALPHA-1062, a drug in testing that may prove to have a significant effect in treating Alzheimer’s Disease.

The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory Sichenzia and Jeff Cahlon.

Click here for a full list of recent transactions headed by SRFC.

Sichenzia Ross Ference Carmel LLP

Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in $7 Million Public Offering of C3is Inc.

c3is logo

Press Release – New York, NY – January 23rd, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Aegis Capital Corp. as underwriter, in its public offering of C3is Inc. (the “Company” or C3is”).

The now-closed offering consisted of 28,000,000 Units, each containing one share of common stock or Pre-Funded Warrant. The above offering resulted in gross proceeds to the Company of approximately $7.0 million, before deducting underwriting discounts and other estimated expenses payable by the Company. The offering was upsized from $6.0 million.

C3is is an international shipping transportation company, providing dry bulk and crude oil tanker seaborne services. Their clientele includes major national and private industrial users, commodity producers, and traders.

The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory Sichenzia, Darrin M. Ocasio, and Jeff Cahlon, and associate Christian Lichtenberger.

Click here for a full list of recent transactions headed by SRFC.

Sichenzia Ross Ference Carmel LLP

Sichenzia Ross Ference Carmel LLP Represents Titan Partners Group in $15 Million Public Offering of SurgePays, Inc.

Press Release – New York, NY – January 18th, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Titan Partners Group (the “Underwriter”), in its public offering of SurgePays, Inc.: a technology and telecom company focused on the underbanked and underserved.

The offering consisted of 2,678,571 shares of its common stock (or pre-funded warrants in lieu thereof) at a public offering price of $5.60 per share, for aggregate gross proceeds of approximately $15 million, before deducting underwriting discounts and other offering expenses.

SurgePays has granted the underwriters a 45-day option to purchase up to 401,785 additional shares of its common stock sold in the offering on the same terms and conditions. The Company expects to close the offering on January 22, 2024, subject to customary conditions.

The Sichenzia Ross Ference Carmel LLP team was led by partners Ross Carmel and Brian Margolis, and law clerk Soumya Cheedi.

Click here for a full list of recent transactions headed by SRFC.

Sichenzia Ross Ference Carmel LLP

Sichenzia Ross Ference Carmel LLP to Sponsor EF Hutton’s Annual Global Conference

Press Release – New York, NY – January 18th, 2024Sichenzia Ross Ference Carmel LLP is pleased to announce that it will be sponsoring EF Hutton’s Annual Global Conference, showcasing multiple public and private companies across multiple industries in an intimate setting.

This event will feature several key high-ranking executives from said companies to convey their stories to an extensive audience which includes institutional investors, high-net-worth individuals, corporate clients, and exclusive members of the press.

EF Hutton is an investment bank headquartered in New York, NY that provides strategic advice and financing solutions to middle market and emerging growth companies. EF Hutton has a proven track record of providing superior strategic advice to clients across the globe in any sector, with unique access to capital from the USA, Asia, Europe, UAE, and Latin America.

The annual event will take place on Wednesday, May 15th, 2024, from 8:30am – 3:15pm at the beautiful Plaza Hotel in New York City. The event features a continental breakfast at 7:30am, and a working lunch at 11:30am.

If you are interested in attending the event, please register by clicking here. We look forward to connecting with all of our valued partners at the event!

Sichenzia Ross Ference Carmel LLP Represents EF Hutton in $1.8 Million Public Offering of DatChat, Inc.

datchat logo

Press Release – New York, NY – January 18th, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented EF Hutton (the “Underwriter”), in its public offering of DatChat, Inc.’s (the “Company” or “DatChat”) common stock.

The offering consisted of 972,972 shares of its common stock (or pre-funded warrants in lieu thereof) at a public offering price of $1.85 per share, for aggregate gross proceeds of approximately $1.8 million, before deducting underwriting discounts and other offering expenses.

In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 145,945 shares of common stock (or pre-funded warrants in lieu thereof) at the public offering price per share, less the underwriting discounts to cover over-allotments, if any. The offering is expected to close on January 19, 2024, subject to satisfaction of customary closing conditions.

DatChat is a metaverse-focused secure messaging and social media company. Their goal is to make the metaverse simple, fun, and accessible for all while maintaining privacy protection across the board. Their flagship product, the DatChat Messenger & Private Social Network, is a privacy platform and mobile application that provides safe and private communication and sharing.

The Sichenzia Ross Ference Carmel LLP team was led by partners Ross Carmel and Avital Perlman, and associate Christian Lichtenberger.

Click here for a full list of recent transactions headed by SRFC.

Sichenzia Ross Ference Carmel LLP

Sichenzia Ross Ference Carmel LLP Represents A2Z Smart Technologies Corp. in $4.7 Million Registered Direct Offerings

Press Release – New York, NY – January 17th, 2024 –Sichenzia Ross Ference Carmel LLP announced today that it represented A2Z Smart Technologies Corp. (the “Company”), (NASDAQ: AZ)(TSXV: AZ), a global innovator in innovative technology solutions, in the Company’s $4.7 million registered direct offerings.

The Company on January 16th, 2023 sold 2,806,302 common shares, at a purchase price of $1.15 per share, alongside with warrants to purchase 1,403,151 shares at a price of $1.50 per share, for aggregate gross proceeds of approximately $3.23 million. As previously disclosed, the Company also raised $1.5 million through the sale of common shares and warrants in December 2023.

The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory Sichenzia and Avital Perlman, associate Kayla Scoccola, and law clerk Rohini Sud.

Click here for a full list of recent transactions headed by SRFC.

Sichenzia Ross Ference Carmel LLP

Sichenzia Ross Ference Carmel LLP Represents VCI Global Limited in $2.75 Million Public Offering

VCI global limited logo

Press Release – New York, NY – January 12th, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented VCI Global Limited (the “Company” or “VCI”) (NASDAQ: VCIG). Today, it announced the closing of its common stock public offering, with gross proceeds of approximately $2.75 million, before deducting placement agent fees and other expenses.

The offering consisted of 2,200,000 ordinary shares and accompanying Series A warrants to purchase up to 2,200,000 ordinary shares (“Series A Warrants”) and Series B Warrants to purchase up to 2,200,000 ordinary shares (“Series B Warrants”, together with Series A Warrants, collectively the “Series Warrants”) at a combined offering price of $1.25 per ordinary share and associated Series Warrants.

VCI Global is a business consultancy agency, with key focuses on capital market consultancy, marketing consultancy, and technology consultancy. The Company provides business and boardroom strategy services, investor relation services, initial public offering, marketing, real estate consultancy, and technology consultancy services. Its clients range from small-medium enterprises and government-linked agencies to publicly traded companies across a broad array of industries. g.

The Sichenzia Ross Ference Carmel LLP team was led by partners Ross Carmel and Jeffrey Wofford, counsel Jeff Hua, and associate Tong Wu.

Click here for a full list of recent transactions headed by SRFC.

Sichenzia Ross Ference Carmel LLP
1 2 3 10